{
    "data": [
        {
            "title": "A Look At FTI Consulting (FCN) Valuation After Strong Results And Upbeat 2026 Guidance",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Why FTI Consulting‚Äôs latest earnings matter for shareholders</h2> <p>FTI Consulting (FCN) just released fourth quarter and full year 2025 results alongside fresh 2026 guidance. This puts new numbers around how the business is performing today and what management expects next.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-fcn/fti-consulting\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for FTI Consulting.</a></p> <p>The 5.1% 1 day share price return after the results, with the stock now at $168.11, comes after a mixed few months where a 30 day share price decline of 8.1% contrasts with a modestly positive 1 year total shareholder return of 2.0%. This suggests recent trading momentum has picked up as investors react to the earnings beat and 2026 guidance.</p> <p>If these earnings have you thinking about where professional services and technology intersect, it could be a good moment to check out <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_founder_led\" href=\"https://simplywall.st/discover/investing-ideas/473625/top-founder-led-companies/us\" rel=\"noopener noreferrer\" target=\"_blank\">20 top founder-led companies</a> as potential next ideas.</p> <p>With FTI Consulting posting higher quarterly sales and diluted EPS alongside 2026 guidance that points to more revenue and earnings, you now have to ask yourself whether there is still upside here or whether the market is already pricing in that growth.</p> <h2>Most Popular Narrative: 5.3% Undervalued</h2> <p>With FTI Consulting closing at $168.11 against a narrative fair value of $177.50, the current price sits below what this widely followed view considers reasonable, and that gap comes from some very specific assumptions about growth and profitability.</p> <blockquote> <p><em>The consulting industry's trend toward consolidation and the challenging macro climate are expected to drive \"shakeouts\" among weaker competitors, strengthening FTI's competitive position, client retention, and potential for market share gains, all of which could result in sustainable margin expansion and earnings growth.</em></p> </blockquote> <p><em><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/didodtsg-fcn-revenue-outlook-adjustments-and-cfo-transition-will-shape-next-chapter\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></em></p> <p>Want to see what sits behind that confidence in margins and earnings? The narrative leans on steady revenue progress, firmer profitability, and a future earnings multiple that is lower than many peers. The key point is how those moving parts line up over several years. If you want to understand the full playbook behind the $177.50 fair value, the complete narrative spells out every assumption.</p> <p>In this narrative, discounting future earnings back at just over 7% and pairing mid single digit revenue growth with higher profit margins creates a path that supports the current fair value estimate. Analysts also assume fewer shares on issue and a future P/E that is below where the broader professional services space sits today, which together help close the gap between today‚Äôs price and that $177.50 figure.</p> <p><strong>Result: Fair Value of $177.50 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/didodtsg-fcn-revenue-outlook-adjustments-and-cfo-transition-will-shape-next-chapter\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, there are clear watchpoints, including pressure on higher billing rates if competition intensifies and the risk that automation could chip away at some consulting demand.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-fcn/fti-consulting\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this FTI Consulting narrative.</a></p> <h2>Another View: Cash Flows Tell A Different Story</h2> <p>While the narrative fair value of $177.50 suggests FTI Consulting is 5.3% undervalued, our DCF model points in the opposite direction, with the shares trading well above an estimated future cash flow value of $0.16. That is a very large gap. Which signal do you trust more: earnings power or cash flows?</p> <p><a class=\"company-report-links\" data-vars-link-type=\"alternate_dcf_cta\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-fcn/fti-consulting/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Look into how the SWS DCF model arrives at its fair value.</a></p> <p></p><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/commercial-services/nyse-fcn/fti-consulting/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"FCN Discounted Cash Flow as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/40098b7d-2adb-4c5e-b295-ff1576b3672b/chart/dcf?date=2026-02-26\" width=\"746\"/></a><figcaption>FCN Discounted Cash Flow as at Feb 2026</figcaption></figure><p> </p><p>Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (<a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-fcn/fti-consulting\" rel=\"noopener noreferrer\" target=\"_blank\">check out FTI Consulting for example</a>). We show the entire calculation in full. You can track the result in your <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> and be alerted when this changes, or use our stock screener to discover <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 high quality undervalued stocks</a>. If you <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/stock-screener\" rel=\"noopener noreferrer\" target=\"_blank\">save a screener</a> we even alert you when new companies match - so you never miss a potential opportunity.</p> <h2>Next Steps</h2> <p>With such mixed signals around value and earnings power, it makes sense to move quickly and examine the numbers yourself to decide what really matters. To see what the market is currently optimistic about, take a closer look at the <a class=\"company-report-links\" data-vars-link-type=\"cta_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-fcn/fti-consulting\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If this update has you rethinking where your next opportunity could come from, do not stop at one stock. Use the screener to quickly surface fresh ideas tailored to you.</p> <ul> <li>Target potential mispricings by scanning our list of <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 high quality undervalued stocks</a>, which combines quality fundamentals with prices that may not fully reflect them.</li> <li>Strengthen your income focus by reviewing <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_dividend\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/us\" rel=\"noopener noreferrer\" target=\"_blank\">15 dividend fortresses</a>, a set of companies offering yields that stand out for investors who care about regular cash returns.</li> <li>Prioritize resilience by checking the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">79 resilient stocks with low risk scores</a>, a group of businesses that score well on financial stability and measured risk factors.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-27 10:25:56",
            "link": "https://simplywall.st/stocks/us/commercial-services/nyse-fcn/fti-consulting/news/a-look-at-fti-consulting-fcn-valuation-after-strong-results",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "A Look At New Oriental Education & Technology Group‚Äôs (EDU) Valuation After Recent Share Price Weakness",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Recent performance snapshot</h2> <p>New Oriental Education &amp; Technology Group (EDU) has recently drawn attention after a mixed run in its share price, with a 1 day return of 2.07% and a 7 day decline of 6.76%.</p> <p>Over the past month the stock is roughly flat, while the past 3 months show a total return of 8.99%. Over a 1 year period, the total return stands at 20.51%, set against a 3 year total return of 33.52% and a 5 year total return decline of 67.80%.</p> <p>The shares last closed at US$55.74, and the company currently carries a value score of 3 on the provided scale.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-edu/new-oriental-education-technology-group\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for New Oriental Education &amp; Technology Group.</a></p> <p>For New Oriental, the recent 7 day share price decline of 6.76% and a year to date share price decline of 3.61% sit alongside a 90 day share price return of 8.99% and a 1 year total shareholder return of 20.51%. This suggests momentum has cooled in the short term, while longer term holders have still seen gains.</p> <p>If this shift in sentiment has you thinking about where else capital could work hard, it might be a good moment to broaden your search and check out <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_founder_led\" href=\"https://simplywall.st/discover/investing-ideas/473625/top-founder-led-companies/us\" rel=\"noopener noreferrer\" target=\"_blank\">20 top founder-led companies</a>.</p> <p>With New Oriental trading at US$55.74 and sitting at a discount to analyst targets and some intrinsic estimates, investors now face a key question: is this a genuine value opportunity, or is future growth already priced in?</p> <h2>Most Popular Narrative: 13.6% Undervalued</h2> <p>With New Oriental shares at US$55.74 against a narrative fair value of US$64.49, the current setup centers on whether its cash generation can justify that gap under a 7.74% discount rate.</p> <blockquote> <p><em>Continued investment and rollout of omnichannel online merge offline (OMO) and AI-driven systems are enabling operating leverage, cost reductions, and higher efficiency in delivery, which is already resulting in improved operating margins (410bps YoY in core business), supporting future earnings growth through both topline expansion and margin expansion.</em></p> </blockquote> <p><em><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/u6bu8xt3-analysts-raise-price-target-for-new-oriental-amid-resilient-margins-and-mixed-growth-outlook\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></em></p> <p>Curious what kind of revenue climb, margin shift, and future earnings multiple need to line up to support that valuation gap? The full narrative spells out the growth runway, profit profile, and re-rating assumptions that sit behind that US$64.49 figure.</p> <p><strong>Result: Fair Value of US$64.49 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/u6bu8xt3-analysts-raise-price-target-for-new-oriental-amid-resilient-margins-and-mixed-growth-outlook\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, that story could wobble if overseas study demand softens further, or if tougher competition in non academic segments squeezes margins more than expected.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-edu/new-oriental-education-technology-group\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this New Oriental Education &amp; Technology Group narrative.</a></p> <h2>Next Steps</h2> <p>If this mix of upside potential and risks leaves you on the fence, now is a good time to check the data yourself and pressure test the story. To see what more optimistic investors are focusing on, take a look at <a class=\"company-report-links\" data-vars-link-type=\"cta_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-edu/new-oriental-education-technology-group\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If New Oriental has sharpened your thinking, do not stop with one stock. Use the tools at your fingertips to compare different themes, risk levels, and income profiles before you commit fresh capital.</p> <ul> <li>Target potential value opportunities by checking companies that screen as attractively priced with solid fundamentals through <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 high quality undervalued stocks</a>.</li> <li>Strengthen the defensive side of your portfolio by focusing on companies with cash rich, resilient balance sheets using the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/us\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (41 results)</a>.</li> <li>Set up a reliable income stream by reviewing companies highlighted as higher yielding payers in the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_dividend\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/us\" rel=\"noopener noreferrer\" target=\"_blank\">15 dividend fortresses</a>.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if New Oriental Education &amp;amp; Technology Group might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/us/consumer-services/nyse-edu/new-oriental-education-technology-group/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:25:56",
            "link": "https://simplywall.st/stocks/us/consumer-services/nyse-edu/new-oriental-education-technology-group/news/a-look-at-new-oriental-education-technology-groups-edu-valua",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Northland Power Q4 Profitability Contrasts With Trailing Losses And Tests Bullish Earnings Narratives",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Northland Power FY 2025 earnings snapshot</h2> <p>Northland Power (TSX:NPI) closed out FY 2025 with Q4 revenue of C$725.3 million and basic EPS of C$0.95, while its trailing 12 month profile still reflects a loss with EPS at C$0.62 and net income of C$163.2 million. The company has seen quarterly revenue move from C$582.3 million in Q4 2024 to C$725.3 million in Q4 2025, alongside EPS shifting from C$0.49 to C$0.95 over the same period. This sets up an earnings picture where recent quarterly profitability contrasts with a loss making trailing 12 month base. For investors, the mix of positive Q4 earnings on top of loss making full year figures keeps the spotlight firmly on how margins hold up from here.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/ca/utilities/tsx-npi/northland-power-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Northland Power.</a> <p>With the headline numbers on the table, the next step is to see how this earnings profile lines up against the key narratives around Northland Power's profitability, growth potential, and risk profile that investors have been talking about.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/n65x0uiq-grid-storage-and-offshore-wind-will-deliver-a-brighter-future-uxos\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Northland Power</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/ca/utilities/tsx-npi/northland-power-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"TSX:NPI Revenue &amp; Expenses Breakdown as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/eb1e3ff3-ac2f-404c-899f-e4a48d235412/chart/revenue-and-expenses-breakdown?date=2026-02-26\" width=\"746\"/></a><figcaption>TSX:NPI Revenue &amp; Expenses Breakdown as at Feb 2026</figcaption></figure> <h2>Loss making over C$160 million on a 12 month view</h2> <ul> <li>On a trailing 12 month basis to Q4 2025, Northland Power recorded total revenue of about C$2.4b and a net loss of C$163.2 million, which contrasts with Q4 alone showing net income of C$249.5 million.</li> <li>What stands out for the bearish narrative is that this 12 month loss comes after multiple loss making quarters, including Q3 2025 net loss of C$414.0 million and Q2 2025 net loss of C$64.1 million. Critics argue this keeps cash flow and long term earnings visibility under pressure even as individual quarters like Q4 look strong.\n    <ul> <li>Bears also point to weak coverage of interest costs and dividends, with earnings currently not covering a 3.32% dividend yield or interest expense. This ties directly into concerns about elevated debt and C$9b already spent plus C$6b still expected on Baltic Power and Hai Long.</li> <li>At the same time, consensus commentary about step changes in EBITDA from new offshore wind and storage projects is hard to reconcile with the recent pattern of trailing losses, including a trailing loss of C$285.9 million just one quarter earlier in Q3 2025.</li> </ul> </li> </ul> Northland‚Äôs recent loss pattern and debt funded build out give cautious investors plenty to question in the more optimistic forecasts of future earnings power. <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bear_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêª Northland Power Bear Case</strong></a> <h2>Slow 1.7% revenue growth versus wider market</h2> <ul> <li>Over the past 12 months, revenue has grown by about 1.7% per year compared to a 6.1% per year forecast for the Canadian market, even though quarterly revenue moved from C$582.3 million in Q4 2024 to C$725.3 million in Q4 2025.</li> <li>Analysts' bullish case leans heavily on new projects like Hai Long and Baltic Power and on grid scale storage, arguing that these additions can lift margins from about 2.3% loss making levels today toward 16.5% over three years. However, the current modest 1.7% revenue growth rate and history of wind resource issues and curtailments in places like the German offshore assets show how sensitive actual revenue can be to weather and power price conditions.\n    <ul> <li>On the supportive side for bulls, Q4 2025 revenue of C$725.3 million and net income of C$249.5 million follow Q4 2024 revenue of C$582.3 million and net income of C$126.8 million, which aligns with the view that new assets and better contract mix can improve earnings in stronger periods.</li> <li>Against that, the same 12 month data set still shows the business unprofitable and dropping several onshore and battery projects in Ontario, Alberta, and New York. This pushes back on the idea that growth from here is straightforward or that all pipeline projects will translate into higher revenue.</li> </ul> </li> </ul> For investors weighing that slower 1.7% revenue growth against the big project pipeline, it helps to see how others frame the trade off between new capacity, weather risk, and contract quality. <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bull_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêÇ Northland Power Bull Case</strong></a> <h2>Valuation sits below both DCF fair value and peers</h2> <ul> <li>At a current share price of C$21.69, Northland Power trades below the DCF fair value of about C$23.78 and at a P/S of 2.3x, compared with 3.0x for the broader North American renewable energy industry and 3.5x for peers.</li> <li>Consensus narrative suggests that expansion into grid scale storage and offshore wind and the use of long term, inflation linked contracts could justify these lower multiples over time. Yet the combination of a trailing loss of C$163.2 million and interest expenses that are not well covered by earnings means the current discount can also be read as the market pricing in balance sheet risk and a reliance on analyst forecasts that expect earnings of C$454.1 million by around 2028.\n    <ul> <li>The spread between the share price of C$21.69 and DCF fair value of C$23.78, plus a forecast earnings growth rate of about 40% per year and an analyst target of C$22.42, are the main numbers backing the view that the shares are not expensive\n<h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/n65x0uiq-grid-storage-and-offshore-wind-will-deliver-a-brighter-future-uxos\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Northland Power on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>With bulls and bears both making strong cases here, it is worth getting familiar with the full set of numbers and forming your own view quickly. To see how concerns stack up against potential upside, take a look at the <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/ca/utilities/tsx-npi/northland-power-shares\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards and 2 important warning signs</a> and judge the balance for yourself.</p> <h2>Explore Alternatives</h2> <p>Northland Power is still working through a C$163.2 million loss on a 12 month view, modest 1.7% revenue growth, and debt related concerns.</p> <p>If that combination of recent losses and balance sheet pressure feels uncomfortable, you can quickly compare it with companies in our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/ca\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (10 results)</a> that prioritize financial resilience.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p></li></ul></li></ul><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Northland Power might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/ca/utilities/tsx-npi/northland-power-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:25:56",
            "link": "https://simplywall.st/stocks/ca/utilities/tsx-npi/northland-power-shares/news/northland-power-q4-profitability-contrasts-with-trailing-los",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Chime Financial (CHYM) Q2 Loss Of US$923m Fuels Bearish Profitability Narratives",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Chime Financial (CHYM) closed out FY 2025 with Q4 revenue of US$596.4 million and a basic EPS loss of US$0.12. Trailing 12 month figures show revenue of about US$2.2 billion and a basic EPS loss of US$4.27, keeping the story firmly in loss-making territory. Over recent periods the company has seen revenue move from US$475.2 million in Q4 2024 to US$596.4 million in Q4 2025. This has come alongside quarterly EPS that has swung between a profit of US$0.20 in Q1 2025 and a loss of US$7.29 in Q2 2025, so investors are watching how quickly that volatility settles into more stable margins.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nasdaq-chym/chime-financial\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Chime Financial.</a> <p>With the latest numbers on the table, the next step is to see how this mix of rapid revenue progress and uneven profitability lines up with the key narratives investors have been using to frame Chime Financial‚Äôs story.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/tgtbueur-update-for-chime-financial\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Chime Financial</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nasdaq-chym/chime-financial/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqGS:CHYM Revenue &amp; Expenses Breakdown as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/93e8c166-1574-412a-8955-93ccc8007b9e/chart/revenue-and-expenses-breakdown?date=2026-02-26\" width=\"746\"/></a><figcaption>NasdaqGS:CHYM Revenue &amp; Expenses Breakdown as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Revenue Nears US$2.2b While Losses Remain Heavy</h2> <ul> <li>On a trailing 12 month basis, Chime generated about US$2.2b of revenue against a net loss of roughly US$1.0b, so this is a business with strong top line scale that is still firmly in loss making territory.</li> <li>What stands out for the bullish narrative is that analysts are pairing this 30.7% revenue growth over the last year with forecast earnings growth of about 116.54% per year,\n    <ul> <li>Revenue moving from US$1.7b to about US$2.2b over the last 12 months aligns with the bullish view that digital banking adoption and higher value products like MyPay and Chime Card can support future growth.</li> <li>At the same time, the current trailing 12 month loss of roughly US$1.0b is a reminder that the optimistic margin assumptions in the bullish case depend on a significant shift from today‚Äôs loss making base.</li> </ul> </li> </ul> <p>Some bulls argue this mix of US$2.2b in revenue and heavy current losses could be the setup for a sharp earnings swing if their margin expectations play out, but they are starting from a very loss heavy year.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_bull_narrative_link\" href=\"https://simplywall.st/narratives/tgtbueur-update-for-chime-financial\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêÇ Chime Financial Bull Case</strong></a> <h2>Quarterly Profit Swings Highlight Execution Risk</h2> <ul> <li>Within FY 2025, net income ranged from a profit of US$12.9 million in Q1 to a loss of US$923.4 million in Q2, with Q3 and Q4 losses of US$54.7 million and US$44.8 million, so profitability has moved around a lot within a single year.</li> <li>Bears focus on this pattern when they question how smooth the road to profitability might be,\n    <ul> <li>The very large loss in Q2 2025, alongside much smaller losses in Q3 and Q4, supports the cautious narrative that scaling products like MyPay and instant loans could expose Chime to earnings volatility if credit costs or operating expenses spike again.</li> <li>Even with revenue between US$518.7 million and US$596.4 million across the 2025 quarters, the shift from a small profit in Q1 to sizable losses later in the year gives skeptics concrete data to reference when they argue that earnings quality is still unproven.</li> </ul> </li> </ul> <p>Skeptical investors often point to the jump from a US$12.9 million profit to a US$923.4 million loss within the same year as a key reason to treat any profitability timelines with caution.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/q2p2b8jf-update-for-chime-financial\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª Chime Financial Bear Case</strong></a> <h2>Premium P/S Multiple Relies On Growth Story</h2> <ul> <li>Chime is trading on a P/S ratio of 4.2x compared with peers at 2.0x and the US Diversified Financial industry at 2.4x, so the market is currently valuing each dollar of Chime‚Äôs sales at a clear premium to its reference group.</li> <li>Consensus narrative ties that higher multiple to expectations for faster growth,\n    <ul> <li>Forecast revenue growth of 16.7% per year compared with 10.4% for the broader US market is one reason investors may be comfortable paying more than peers for each dollar of current revenue.</li> <li>At the same time, the company is still loss making on a trailing 12 month basis, so the premium P/S ratio is being supported by growth forecasts rather than current profitability, which leaves less room if those forecasts are revised lower.</li> </ul> </li> </ul> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/tgtbueur-update-for-chime-financial\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Chime Financial on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>If the combination of strong revenue scale, heavy losses and competing narratives leaves you unsure, take a moment to review the numbers yourself. Move quickly to form your own stance, then check what our data driven view highlights with <a class=\"company-report-links\" data-vars-link-type=\"cta_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nasdaq-chym/chime-financial\" rel=\"noopener noreferrer\" target=\"_blank\">2 key rewards</a>.</p> <h2>See What Else Is Out There</h2> <p>Chime Financial combines roughly US$2.2b of revenue with heavy losses and sharp quarterly profit swings, so earnings quality and consistency remain key pressure points.</p> <p>If that level of earnings volatility has you wanting something steadier, check out our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">79 resilient stocks with low risk scores</a> built to highlight companies with more consistent performance profiles today.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-27 10:25:56",
            "link": "https://simplywall.st/stocks/us/diversified-financials/nasdaq-chym/chime-financial/news/chime-financial-chym-q2-loss-of-us923m-fuels-bearish-profita",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Is It Time To Revisit Daiichi Sankyo (TSE:4568) After Recent Share Price Weakness?",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>If you are wondering whether Daiichi Sankyo Company is attractively priced right now, this article will walk you through what the numbers are saying about its share price.</li> <li>The stock last closed at ¬•3,051, with returns of 3.7% over the past 7 days, 0.2% over 30 days, and year to date and 1 year returns of 13.6% decline and 10.9% decline, alongside a 25.3% decline over 3 years and a 6.5% gain over 5 years.</li> <li>These mixed return figures set the stage for a closer look at what is driving sentiment around the company. In this article, we will focus on how its current share price lines up with different valuation views rather than short term news flow.</li> <li>Daiichi Sankyo Company currently has a <a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/jp/pharmaceuticals-biotech/tse-4568/daiichi-sankyo-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">valuation score of 5 out of 6</a>, which means it screens as undervalued on most of the checks we run. Next we will look at what each valuation approach suggests, before finishing with a way to tie them together into a clearer picture of value.</li> </ul> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_industry_underperformer\" href=\"https://www.simplywall.st/stocks/jp/pharmaceuticals-biotech/tse-4568/daiichi-sankyo-shares/future\" rel=\"noopener noreferrer\" target=\"_blank\">Find out why Daiichi Sankyo Company's -10.9% return over the last year is lagging behind its peers.</a></p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Approach 1: Daiichi Sankyo Company Discounted Cash Flow (DCF) Analysis</h3> <p>A Discounted Cash Flow, or DCF, model estimates what a company might be worth by projecting its future cash flows and then discounting those back to today to get a single present value figure.</p> <p>For Daiichi Sankyo Company, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is a loss of ¬•46.2b, so the valuation leans heavily on expected improvements in future cash generation rather than recent cash flow alone.</p> <p>Analysts have provided free cash flow estimates out to 2030, with projections such as ¬•278.8b for 2026 and ¬•359.7b for 2030. Beyond the analyst horizon, Simply Wall St extrapolates additional years of cash flows to complete the 10 year projection, all still in ¬• and then discounted back to today.</p> <p>Putting all of those cash flows together, the DCF model suggests an estimated intrinsic value of about ¬•5,305 per share, compared with the recent share price of ¬•3,051. That gap implies the stock screens as around 42.5% undervalued on this measure alone.</p> <p><strong>Result: UNDERVALUED</strong></p> <p>Our Discounted Cash Flow (DCF) analysis suggests Daiichi Sankyo Company is undervalued by 42.5%. Track this in your <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_undervalued\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_undervalued\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>, or discover <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/jp\" rel=\"noopener noreferrer\" target=\"_blank\">18 more high quality undervalued stocks</a>.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/jp/pharmaceuticals-biotech/tse-4568/daiichi-sankyo-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"4568 Discounted Cash Flow as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/3da34022-ad84-492d-b476-e9d83a1ae4e6/chart/dcf?date=2026-02-26\" width=\"746\"/></a><figcaption>4568 Discounted Cash Flow as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"dcf_explainer_cta\" href=\"https://www.simplywall.st/stocks/jp/pharmaceuticals-biotech/tse-4568/daiichi-sankyo-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Daiichi Sankyo Company.</a></p> <h3>Approach 2: Daiichi Sankyo Company Price vs Earnings (P/E)</h3> <p>For a profitable business, the P/E ratio is a useful shorthand for how much investors are paying for each unit of earnings. This makes it a practical way to compare companies of different sizes within the same sector.</p> <p>What counts as a ‚Äúnormal‚Äù P/E depends a lot on expectations and risk. Higher expected earnings growth or perceived stability can support a higher P/E, while lower growth or higher risk usually point to a lower, more cautious P/E range.</p> <p>Daiichi Sankyo Company currently trades on a P/E of 18.5x. That is above the Pharmaceuticals industry average of 16.0x, but below the peer group average of 31.3x. Simply Wall St also calculates a proprietary ‚ÄúFair Ratio‚Äù for the stock of 32.3x, which is the P/E it might reasonably trade on given factors such as its earnings growth profile, industry, profit margin, market cap and specific risks.</p> <p>This Fair Ratio is more tailored than a simple peer or industry comparison because it adjusts for the company‚Äôs own characteristics rather than assuming it should trade in line with broad averages. With the current P/E of 18.5x sitting well below the Fair Ratio of 32.3x, the shares currently appear undervalued on this metric.</p> <p><strong>Result: UNDERVALUED</strong></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/jp/pharmaceuticals-biotech/tse-4568/daiichi-sankyo-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"TSE:4568 P/E Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/3da34022-ad84-492d-b476-e9d83a1ae4e6/chart/pe-multiple-vs-industry?date=2026-02-26\" width=\"746\"/></a><figcaption>TSE:4568 P/E Ratio as at Feb 2026</figcaption></figure> <p>P/E ratios tell one story, but what if the real opportunity lies elsewhere? <a class=\"company-report-links\" data-vars-link-type=\"cta_preferred_multiple_contextual\" href=\"https://simplywall.st/discover/investing-ideas/473625/top-founder-led-companies/jp\" rel=\"noopener noreferrer\" target=\"_blank\">Start investing in legacies, not executives. Discover our 12 top founder-led companies</a>.</p> <h3>Upgrade Your Decision Making: Choose your Daiichi Sankyo Company Narrative</h3> <p>Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, where you write a simple story about Daiichi Sankyo Company that ties your view on its drugs, risks and opportunities to a set of numbers like future revenue, earnings, margins and a fair value estimate.</p> <p>A Narrative on Simply Wall St links three things in one place: the business story you believe, the forecast that matches that story, and the fair value that follows from those assumptions, all presented as an easy tool on the Community page that millions of investors already use.</p> <p>You can then compare that fair value to the current share price to help decide whether you see Daiichi Sankyo Company as priced above or below your expectations. Your Narrative will automatically refresh when new earnings, news or analyst updates are added, so your view remains current.</p> <p>For example, one Daiichi Sankyo Company Narrative could lean closer to the higher analyst fair value around ¬•6,300, built on stronger growth and margins. Another could sit nearer the lower fair value around ¬•3,623, built on more cautious assumptions about growth, profitability and future P/E. Both perspectives can coexist side by side on the platform.</p> <p>Do you think there's more to the story for Daiichi Sankyo Company? <a class=\"company-report-links\" data-vars-link-type=\"cta_create_narrative_community\" href=\"https://simplywall.st/stock/TSE/4568\" rel=\"noopener noreferrer\" target=\"_blank\">Head over to our Community to see what others are saying!</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/jp/pharmaceuticals-biotech/tse-4568/daiichi-sankyo-shares\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"TSE:4568 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/3da34022-ad84-492d-b476-e9d83a1ae4e6/chart/quote-price?date=2026-02-26\" width=\"746\"/></a><figcaption>TSE:4568 1-Year Stock Price Chart</figcaption></figure> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-27 10:20:55",
            "link": "https://simplywall.st/stocks/jp/pharmaceuticals-biotech/tse-4568/daiichi-sankyo-shares/news/is-it-time-to-revisit-daiichi-sankyo-tse4568-after-recent-sh",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Simmons First National (SFNC) Net Interest Margin Rebound Tests Bearish Profitability Narratives",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Simmons First National (SFNC) closed out FY 2025 with fourth quarter revenue of US$233.9 million and basic EPS of US$0.54, following a turbulent year in which trailing twelve month figures show revenue of US$37.4 million and a basic EPS loss of US$2.96. Over recent quarters, the company has seen quarterly revenue move from US$162.7 million in Q3 2024 to US$195.2 million in Q4 2024, then to US$182.8 million, US$202.2 million and US$233.9 million through Q1 to Q4 2025. Basic EPS shifted from US$0.20 in Q3 2024 to US$0.38 in Q4 2024, then US$0.26, US$0.43, a loss of US$4.01 and back to US$0.54 in Q4 2025. With trailing results still showing an annual loss and earlier quarters marked by compressed profitability, the latest print puts the focus firmly on whether margins can stabilise from here.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/banks/nasdaq-sfnc/simmons-first-national\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Simmons First National.</a> <p>With the headline numbers set, the next step is to see how this earnings profile lines up with the current bull and bear narratives investors are using to frame Simmons First National.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/vjzcq8w3-urbanization-and-digital-adoption-will-transform-us-banking-x4si\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Simmons First National</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/banks/nasdaq-sfnc/simmons-first-national/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqGS:SFNC Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/66a99783-4928-4089-b45d-67659b360ea5/chart/earnings-and-revenue-history?date=2026-02-26\" width=\"746\"/></a><figcaption>NasdaqGS:SFNC Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Loan book steady while problem credits climb</h2> <ul> <li>Total loans stayed around US$17.1b through FY 2025, while non performing loans moved from US$101.7 million in Q3 2024 to US$153.9 million by Q3 2025.</li> <li>Analysts' consensus view talks about healthy commercial and industrial pipelines and higher yielding loans, yet the rise in non performing loans:\n    <ul> <li>Sits alongside commentary about commercial real estate exposure and classification upticks. This could help explain why non performing loans moved above US$150 million for much of 2025.</li> <li>Creates a contrast between the expected support from loan remixing and the credit risk signals that could feed into future loan loss provisions.</li> </ul> </li> </ul> <h2>Net interest margin improves through FY 2025</h2> <ul> <li>Net interest margin moved from 2.74% on a trailing basis at Q4 2024 to 2.95% in Q1 2025, 3.06% in Q2 2025 and 3.5% in Q3 2025.</li> <li>Consensus narrative highlights loan portfolio shifts toward higher yielding variable rate loans and digital investments, and the margin path:\n    <ul> <li>Aligns with the idea that repricing and higher yielding assets are helping, as seen in the move from sub 3% to 3.5% net interest margin by Q3 2025.</li> <li>Also runs into comments about rising expenses and fading deposit repricing gains, which could make sustaining a 3% plus margin harder if cost growth continues.</li> </ul> </li> </ul> Over the last few quarters, this margin trend is one of the key numbers bulls point to when they argue Simmons can support loan growth and earnings quality over time. <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bull_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêÇ Simmons First National Bull Case</strong></a> <h2>Large loss still weighs on full year picture</h2> <ul> <li>Despite Q4 2025 net income of US$78.1 million, trailing twelve month net income sits at a loss of US$397.6 million and basic EPS at a loss of US$2.96, reflecting the Q3 2025 net loss of US$562.8 million.</li> <li>Bears focus on the trailing loss profile and dilution, and the numbers here:\n    <ul> <li>Support that view, with trailing revenue of US$37.4 million and a multi year pattern of worsening losses cited at 36.2% per year even after the profitable Q4 2025.</li> <li>Also interact with the 4.01% dividend yield that is flagged as not well covered by current or forecast earnings, which is an important point for income focused holders.</li> </ul> </li> </ul> For anyone worried that the recent profit prints might mask these larger loss figures, it is worth seeing how cautious analysts frame the downside case in more detail. <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bear_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêª Simmons First National Bear Case</strong></a> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/vjzcq8w3-urbanization-and-digital-adoption-will-transform-us-banking-x4si\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Simmons First National on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>The combination of profit recovery and earlier losses presents a mixed picture, so if you want a clearer view, check the balance of <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/banks/nasdaq-sfnc/simmons-first-national\" rel=\"noopener noreferrer\" target=\"_blank\">2 key rewards and 2 important warning signs</a>.</p> <h2>See What Else Is Out There</h2> <p>Simmons First National is still carrying a trailing net income loss of US$397.6 million, rising non performing loans, and questions about dividend coverage.</p> <p>If those credit and earnings pressures make you uneasy, it could be worth checking out <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">79 resilient stocks with low risk scores</a> to quickly focus on businesses with more resilient profiles.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-27 10:20:55",
            "link": "https://simplywall.st/stocks/us/banks/nasdaq-sfnc/simmons-first-national/news/simmons-first-national-sfnc-net-interest-margin-rebound-test",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Assessing Danaher (DHR) Valuation After Recent Share Price Weakness",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Why Danaher stock may be on your radar today</h2> <p>Danaher (DHR) has been drawing attention after recent share price moves, with the stock around $209.36 and showing mixed returns over the past year, month, and past 3 months.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for Danaher.</a></p> <p>Recent trading has been softer, with a 30 day share price return of an 11.19% decline and a 1 year total shareholder return of 2.41%, so near term momentum looks weaker than the longer term picture.</p> <p>If Danaher‚Äôs recent moves have you reassessing your watchlist, it could be a good moment to broaden your search with our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_healthcare_ai\" href=\"https://simplywall.st/discover/investing-ideas/434426/healthcare-ai/us\" rel=\"noopener noreferrer\" target=\"_blank\">29 healthcare AI stocks</a> as potential next ideas to research.</p> <p>So, with the share price weaker over the past 3 months, but trading at an estimated 8% discount to some intrinsic value models and about 27% below one analyst target, is this a genuine opportunity or is future growth already priced in?</p> <h2>Most Popular Narrative: 21% Undervalued</h2> <p>Compared with Danaher‚Äôs last close at $209.36, the most followed narrative puts fair value closer to the mid $260s, based on projected earnings power and cash flows discounted at an 8.01% rate.</p> <blockquote> <p><em>The sustained advancement of precision medicine and personalized therapies, including new AI-assisted diagnostic solutions and groundbreaking launches in genomics (like support for in vivo CRISPR therapies), positions Danaher's technology portfolio to capture higher-margin growth and drive long-term EBITDA expansion.</em></p> </blockquote> <p><em><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/9dupaeb2-dhr-premium-outlook-will-be-sustained-as-market-recovery-gradually-unfolds\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></em></p> <p>Curious what kind of revenue mix, margin profile and future P/E multiple could justify a fair value well above today‚Äôs share price? The narrative leans on a detailed path for earnings, cash generation and capital allocation that goes far beyond a simple P/E snapshot, and the full story joins those moving parts into one valuation picture.</p> <p><strong>Result: Fair Value of $264.91 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/9dupaeb2-dhr-premium-outlook-will-be-sustained-as-market-recovery-gradually-unfolds\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, you also need to weigh softer bioprocessing demand and policy changes in China, which could pressure revenue, margins and the premium P/E narrative.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this Danaher narrative.</a></p> <h2>Another View: Earnings Multiple Paints A Richer Picture</h2> <p>While the SWS models suggest Danaher is 8.3% below fair value on future cash flows, its current P/E of 41.1x looks expensive next to a 32.1x fair ratio, the 34.7x Life Sciences industry average and 34.3x for peers. Is the premium a cushion or a risk if sentiment cools?</p> <p><a class=\"company-report-links\" data-vars-link-type=\"alternate_preferred_multiple_cta\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">See what the numbers say about this price ‚Äî find out in our valuation breakdown.</a></p> <p></p><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:DHR P/E Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/6e72b874-f689-4638-95f4-c1aeedcf3fe6/chart/pe-multiple-vs-industry?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:DHR P/E Ratio as at Feb 2026</figcaption></figure><p> </p><h2>Next Steps</h2> <p>If this all sounds mixed to you, that is the point. Markets rarely offer a simple story, so check the data yourself and weigh up <a class=\"company-report-links\" data-vars-link-type=\"cta_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards</a>.</p> <h2>Looking for more ideas before you commit?</h2> <p>If you are unsure about adding Danaher right now, use this momentum to widen your research and pressure test your thinking against other clear opportunities.</p> <ul> <li>Spot potential value opportunities by scanning our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 high quality undervalued stocks</a> that combine quality fundamentals with prices that may not fully reflect their current profiles.</li> <li>Prioritise resilience first and check companies filtered by our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">79 resilient stocks with low risk scores</a> so you can focus on businesses with fewer red flags.</li> <li>Hunt for potential early stage winners with strong under the radar fundamentals using our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undiscovered_gems\" href=\"https://simplywall.st/discover/investing-ideas/473622/high-quality-undiscovered-gems/us\" rel=\"noopener noreferrer\" target=\"_blank\">screener containing 24 high quality undiscovered gems</a> before everyone else starts paying attention.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-27 10:20:55",
            "link": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/news/assessing-danaher-dhr-valuation-after-recent-share-price-wea",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Bonheur (OB:BONHR) Margin Improvement Reinforces Bullish Profitability Narrative",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Bonheur (OB:BONHR) FY 2025 earnings snapshot</h2> <p>Bonheur (OB:BONHR) has wrapped up FY 2025 with fourth quarter revenue of NOK2.9b and basic EPS of NOK3, rounding out a trailing twelve month EPS of NOK33.4 and net income of NOK1.4b. The company has seen quarterly revenue range from NOK2.9b to NOK3.4b over 2025, with basic EPS moving from a loss of NOK0.99 in Q1 to NOK20.62 in Q2, NOK10.84 in Q3 and NOK3 in Q4. Trailing twelve month EPS has tracked between NOK21.81 and NOK33.4 over the last six reported periods. With net profit margin improving from 8.2% to 11.4% over the past year, the latest print provides a picture of firmer profitability that investors will weigh against the forward earnings outlook.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/no/capital-goods/ob-bonhr/bonheur-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Bonheur.</a> <p>With the headline numbers on the table, the next step is to see how this earnings run rate lines up with the widely held narratives around Bonheur's growth potential, risk profile and profit trajectory.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/jq8q31gd-floating-wind-and-renewables-will-drive-demand-despite-risks\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Bonheur</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/no/capital-goods/ob-bonhr/bonheur-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"OB:BONHR Revenue &amp; Expenses Breakdown as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/bea6d945-d331-44e5-ad85-1e03aee84bc0/chart/revenue-and-expenses-breakdown?date=2026-02-26\" width=\"746\"/></a><figcaption>OB:BONHR Revenue &amp; Expenses Breakdown as at Feb 2026</figcaption></figure> <h2>Margins strengthen with 11.4% net level</h2> <ul> <li>Over the last twelve months, Bonheur generated NOK12.5b of revenue and NOK1.4b of net income, giving an 11.4% net margin compared with 8.2% a year earlier, alongside 24.8% earnings growth.</li> <li>What stands out for the bullish view is that this higher margin coincides with a period when quarterly revenue has been fairly steady between NOK2.9b and NOK3.6b. That supports the idea that profitability, not just top line, is doing more of the work.\n    <ul> <li>Bulls point to wind service and new wind farms as key earnings drivers, and the move from NOK927.6m to NOK1.4b in trailing net income over the last six reported periods is consistent with that stronger earnings story.</li> <li>At the same time, operational issues mentioned in the bearish narrative, like downtime at certain wind farms and lower power prices in Sweden, are not yet visible in these full year margin and earnings figures. This may make bulls more confident than bears about profit resilience.</li> </ul> </li> </ul> <p>Bulls argue that improved margins and earnings give Bonheur more room to handle project hiccups before profits come under pressure, which is exactly what the latest 11.4% net margin suggests at face value. <a class=\"company-report-links\" data-vars-link-type=\"cta_bull_narrative_link\" href=\"https://simplywall.st/narratives/jq8q31gd-floating-wind-and-renewables-will-drive-demand-despite-risks\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêÇ Bonheur Bull Case</strong></a></p> <h2>P/E of 7.8x vs slower forecast growth</h2> <ul> <li>Bonheur is trading on a trailing P/E of 7.8x, which sits below the Norwegian market at 14.2x, peers at 16.7x and European Industrials at 21.6x. In this dataset, earnings are forecast to decline about 10.8% per year over the next three years and revenue is expected to grow around 0.5% per year versus 3.9% for the wider Norwegian market.</li> <li>Skeptics highlight that a low P/E can be a value signal or a warning, and the bearish narrative leans on those forward numbers to argue that the multiple is low because the market is already factoring in slower growth.\n    <ul> <li>The contrast between 24.8% trailing earnings growth and the expected 10.8% annual decline is exactly the kind of swing bears focus on when they say recent profits may not be a good guide to the next few years.</li> <li>With the share price at NOK260 and analysts in this dataset expecting earnings to shrink while margins ease from 9.4% to 8.2% in the bearish case, the gap between strong recent profitability and softer forecasts is central to that cautious stance.</li> </ul> </li> </ul> <p>Skeptics warn that the combination of a low P/E and projected earnings declines can sometimes signal a value trap rather than a bargain, which is why they lean more heavily on the forward numbers than the trailing growth. <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/id87qqn3-higher-borrowing-costs-and-supply-disruptions-will-strangle-wind-expansion\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª Bonheur Bear Case</strong></a></p> <h2>DCF fair value of NOK87.02 vs NOK260 price</h2> <ul> <li>The DCF fair value in this dataset is NOK87.02 per share, compared with the current share price of NOK260 and an allowed analyst price target of NOK306.00. This sets up a wide range of views on what the business may be worth.</li> <li>Consensus narrative thinking tries to balance this by pointing out that while analysts expect earnings to reach about NOK957.7m by 2028 with margins easing to 7.6%, they are still using a 14.1x P/E on those earnings to justify targets closer to NOK306.00, which sits well above the DCF fair value but below very aggressive bullish assumptions.\n    <ul> <li>The fact that trailing earnings sit at NOK1.4b, above that NOK957.7m 2028 estimate, helps explain why a cash flow model might point to NOK87.02, while a multiple based on today‚Äôs 7.8x P/E and analysts‚Äô future 14.1x assumption can support higher targets.</li> <li>For you as an investor, the tension between a DCF number far below the market price, a market P/E well below peers and an analyst target at NOK306.00 highlights how sensitive valuation is to which metric you trust most.</li> </ul> </li> </ul> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/jq8q31gd-floating-wind-and-renewables-will-drive-demand-despite-risks\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Bonheur on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>If this mix of bullish and cautious views leaves you unsure, quickly review the numbers yourself and weigh both sides using <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/no/capital-goods/ob-bonhr/bonheur-shares\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards and 1 important warning sign</a>.</p> <h2>See What Else Is Out There</h2> <p>Bonheur's low 7.8x P/E alongside forecasts for annual earnings declines of about 10.8% and lower future margins suggests the current profit story may be fragile.</p> <p>If that mix of weaker earnings expectations and a wide gap between DCF fair value and the share price worries you, check out our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">231 high quality undervalued stocks</a> that pair stronger fundamentals with prices that look more grounded in their cash flow profiles.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Bonheur might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/no/capital-goods/ob-bonhr/bonheur-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:20:55",
            "link": "https://simplywall.st/stocks/no/capital-goods/ob-bonhr/bonheur-shares/news/bonheur-obbonhr-margin-improvement-reinforces-bullish-profit",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "UPS Restructuring Shifts From Amazon To Higher Margin Growth And Valuation",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>UPS (NYSE:UPS) is closing 22 union staffed sortation centers this year, as part of a plan that could shutter up to 200 facilities by 2030.</li> <li>The company is launching a voluntary buyout program for up to 105,000 drivers, targeting about 30,000 job reductions.</li> <li>The restructuring is tied to a pivot away from lower margin Amazon deliveries and toward areas such as healthcare logistics and automation.</li> </ul> <p>UPS, a global parcel delivery and logistics provider, is reshaping how its network is set up as e commerce and business shipping patterns evolve. The company is moving away from a heavy reliance on Amazon volumes and is putting more focus on higher margin categories like healthcare shipments and automated facilities. For investors, the changes highlight how management is rethinking where and how UPS earns its money.</p> <p>Looking ahead, the closures and driver buyout program could meaningfully alter UPS cost base and operational footprint by 2030. The key questions for shareholders will be how effectively UPS reallocates capacity to targeted growth areas and how the restructuring affects service quality, labor relations, and long term profitability.</p> <p>Stay updated on the most important news stories for <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://www.simplywall.st/stocks/us/transportation/nyse-ups/united-parcel-service/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">United Parcel Service</a> by adding it to your <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>. Alternatively, explore our <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/stock/NYSE/UPS\" rel=\"noopener noreferrer\" target=\"_blank\">Community</a> to discover new perspectives on United Parcel Service.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/transportation/nyse-ups/united-parcel-service/future\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:UPS Earnings &amp; Revenue Growth as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/9f1233af-7b08-4d3d-8a56-eac949949657/chart/earnings-and-revenue-growth?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:UPS Earnings &amp; Revenue Growth as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_news_risk_alert\" href=\"https://www.simplywall.st/stocks/us/transportation/nyse-ups/united-parcel-service\" rel=\"noopener noreferrer\" target=\"_blank\">We've flagged 3 risks for United Parcel Service. See which could impact your investment.</a></p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Quick Assessment</h3> <ul> <li><strong>‚öñÔ∏è Price vs Analyst Target</strong>: At US$116.63, UPS trades about 3% above the analyst target of US$113.18, within the 10% band that suggests no clear consensus skew.</li> <li><strong>‚úÖ Simply Wall St Valuation</strong>: Simply Wall St flags UPS as trading roughly 27.7% below its estimated fair value.</li> <li><strong>‚úÖ Recent Momentum</strong>: The 30 day return of about 8.8% shows positive short term price momentum.</li> </ul> <p>There is only one way to know the right time to buy, sell or hold United Parcel Service. Head to Simply Wall St's\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/transportation/nyse-ups/united-parcel-service/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">company report for the latest analysis of United Parcel Service's Fair Value.</a>.</p> <h3>Key Considerations</h3> <ul> <li>üìä The restructuring, facility closures and pivot away from Amazon volumes could reshape how UPS earns its US$88.7b in revenue over time.</li> <li>üìä Keep an eye on cost savings versus restructuring charges, P/E of 17.8 versus the logistics industry average of 19.1, and how healthcare and automation exposure develops.</li> <li>‚ö†Ô∏è With a 5.62% dividend not well covered by earnings or free cash flow, larger upfront restructuring costs or weaker cash generation would matter for income focused holders.</li> </ul> <h3>Dig Deeper</h3> <p>For the full picture including more risks and rewards, check out the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/transportation/nyse-ups/united-parcel-service\" rel=\"noopener noreferrer\" target=\"_blank\">complete United Parcel Service analysis</a>. Alternatively, you can check out the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stock/NYSE/UPS\" rel=\"noopener noreferrer\" target=\"_blank\">community page for United Parcel Service</a> to see how other investors believe this latest news will impact the company's narrative.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-27 10:11:28",
            "link": "https://simplywall.st/stocks/us/transportation/nyse-ups/united-parcel-service/news/ups-restructuring-shifts-from-amazon-to-higher-margin-growth",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Restaurant Brands Investor Day Clarifies Growth Targets And Simplification Plan",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>Restaurant Brands International held its 2026 Investor Day, offering a midpoint update on its long-term plan.</li> <li>The company reaffirmed its multiyear growth targets and detailed progress on its existing initiatives.</li> <li>Management outlined a roadmap to simplify its structure, including plans to sunset the Restaurant Holdings segment by 2027.</li> <li>The event also highlighted priorities for capital allocation and operational focus over the medium term.</li> </ul> <p>Restaurant Brands International, traded as NYSE:QSR, entered this Investor Day with its shares at $69.89 and a return of 11.3% over the past year. Over a longer period, the stock has a 20.9% return over three years and 32.8% over five years, which gives investors some context for how the company has rewarded shareholders over different holding periods.</p> <p>For anyone following NYSE:QSR, the reaffirmed growth goals, structural simplification plans, and clarity on capital allocation provide additional inputs for thinking about the company over the next few years. This Investor Day also updates expectations around how management plans to run the business and where it intends to focus resources as it works toward its multiyear objectives.</p> <p>Stay updated on the most important news stories for <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-qsr/restaurant-brands-international/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Restaurant Brands International</a> by adding it to your <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>. Alternatively, explore our <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/stock/NYSE/QSR\" rel=\"noopener noreferrer\" target=\"_blank\">Community</a> to discover new perspectives on Restaurant Brands International.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-qsr/restaurant-brands-international/future\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:QSR Earnings &amp; Revenue Growth as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/e4455ebd-1d99-43c2-b4cc-ee639087d66e/chart/earnings-and-revenue-growth?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:QSR Earnings &amp; Revenue Growth as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_news_full_picture\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-qsr/restaurant-brands-international\" rel=\"noopener noreferrer\" target=\"_blank\">üì∞ Beyond the headline: 3 risks and 2 things going right for Restaurant Brands International that every investor should see.</a></p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Quick Assessment</h3> <ul> <li><strong>‚öñÔ∏è Price vs Analyst Target</strong>: At $69.89 versus a consensus target of $77.76, the price sits about 10% below where analysts on average see it.</li> <li><strong>‚öñÔ∏è Simply Wall St Valuation</strong>: Shares are described as trading close to estimated fair value, so expectations from the Investor Day are largely reflected in the price.</li> <li><strong>‚úÖ Recent Momentum</strong>: A 30 day return of roughly 3.5% shows modest positive momentum into and around the event.</li> </ul> <p>To explore whether it may be the right time to buy, sell, or hold Restaurant Brands International, you can review Simply Wall St's\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-qsr/restaurant-brands-international/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">company report for the latest analysis of Restaurant Brands International's fair value</a>.</p> <h3>Key Considerations</h3> <ul> <li>üìä The Investor Day reaffirmation of multi year growth targets and the plan to sunset Restaurant Holdings by 2027 provide more clarity on how management intends to sharpen the core business.</li> <li>üìä Watch how margins, the P/E of 26.8 versus the 23.2 industry average, and progress on simplifying the structure track against this roadmap over the next few updates.</li> <li>‚ö†Ô∏è Key risks flagged include debt coverage by operating cash flow and a 3.72% dividend that is not well covered, so monitoring cash generation and payout sustainability as capital is redeployed may be important.</li> </ul> <h3>Dig Deeper</h3> <p>For the full picture including more risks and rewards, you can review the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-qsr/restaurant-brands-international\" rel=\"noopener noreferrer\" target=\"_blank\">complete Restaurant Brands International analysis</a>. You can also visit the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stock/NYSE/QSR\" rel=\"noopener noreferrer\" target=\"_blank\">community page for Restaurant Brands International</a> to see how other investors believe this latest news will impact the company's narrative.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-27 10:11:28",
            "link": "https://simplywall.st/stocks/us/consumer-services/nyse-qsr/restaurant-brands-international/news/restaurant-brands-investor-day-clarifies-growth-targets-and",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "California Water Service Group (CWT) Margin Compression Tests Bullish Earnings Narrative",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>California Water Service Group (CWT) has just wrapped up FY 2025 with fourth quarter revenue of US$220 million and basic EPS of US$0.19, alongside net income of US$11.5 million. The company has seen quarterly revenue move from US$222 million and EPS of US$0.33 in Q4 2024 to US$220 million and EPS of US$0.19 in Q4 2025. On a trailing 12 month basis, EPS was US$2.15 on revenue of about US$1.0 billion and net income of US$128.2 million, setting up a story where investors are weighing earnings growth forecasts against a thinner profit margin profile.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/utilities/nyse-cwt/california-water-service-group\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for California Water Service Group.</a> <p>With the headline numbers on the table, the next step is to see how this earnings print lines up with the widely followed narratives around CWT‚Äôs growth potential, risk profile, and long term profitability story.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/9t2mqp2i-capital-investment-in-water-infrastructure-will-expand-regulated-base-t1di\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about California Water Service Group</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/utilities/nyse-cwt/california-water-service-group/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:CWT Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/64bc4bd4-6a65-4a95-8172-d50dd779dee2/chart/earnings-and-revenue-history?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:CWT Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Margins Under Pressure At 12.8%</h2> <ul> <li>On a trailing 12 month basis, CWT earned US$128.2 million of net income on about US$1.0b of revenue. This works out to a 12.8% net margin compared with 18.4% the prior year.</li> <li>Analysts' consensus view is that long term earnings resilience will come from regulated rate relief and capital investment, and the current 12.8% margin puts extra focus on whether future rate decisions and PFAS cost recovery are enough to support that thesis.\n    <ul> <li>The consensus narrative points to expanding infrastructure and reuse projects as supporting future earnings stability. The drop from 18.4% to 12.8% shows how higher compliance and treatment costs can tighten margins in the meantime.</li> <li>With trailing 12 month net income at US$128.2 million versus US$190.8 million a year earlier, the story now hinges on whether future rate cases and cost recoveries can line up more closely with this higher investment and operating spend.</li> </ul> </li> </ul> <p>Bulls argue these margin pressures are temporary and tied to the timing of rate relief and PFAS recovery, not the earning power of the system over a full cycle. <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bull_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêÇ California Water Service Group Bull Case</strong></a></p> <h2>P/E Sits Between Industry Benchmarks</h2> <ul> <li>CWT currently trades on a 20.7x P/E, above the Global Water Utilities average of 16.8x but below the closer Water Utilities peer average of 24.8x.</li> <li>Bears focus on this mid range P/E together with weaker coverage ratios, arguing that paying more than the global sector average looks demanding while interest and dividends are not well covered.\n    <ul> <li>Consensus data indicates that interest payments are not well covered by earnings and that the 3.01% dividend yield is not well covered by free cash flow, which makes a 20.7x multiple look less comfortable for cautious investors.</li> <li>At the same time, five year earnings growth of 9.1% per year and forecast growth of about 9.6% per year show why some investors still accept a P/E above the global average, even with these balance sheet pressures.</li> </ul> </li> </ul> <p>Skeptics highlight that paying 20.7x earnings while interest and dividend coverage stay tight could leave less room for error if growth or regulation disappoint. <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bear_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêª California Water Service Group Bear Case</strong></a></p> <h2>DCF Fair Value Trails Share Price</h2> <ul> <li>The DCF fair value of US$39.61 sits below the current share price of US$44.59, while the consensus analyst target of US$52.00 is above where the stock trades today.</li> <li>What stands out in the consensus narrative is the gap between these valuation markers and the operational backdrop, where forecast earnings growth of about 9.6% per year and revenue growth of roughly 5.3% per year are being weighed against regulatory and PFAS related cost risks.\n    <ul> <li>The analyst target of US$52.00 assumes earnings rising from about US$135.8 million today to US$187.9 million by around 2028, so any delay in rate cases or higher than expected PFAS capex would matter a lot for whether that path is achieved.</li> <li>At the same time, forecasts for revenue to reach around US$1.1b by 2028 from roughly US$1.0b on a trailing 12 month basis illustrate how much of the valuation debate comes down to modest top line growth supporting higher margins and returns over time.</li> </ul> </li> </ul> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/9t2mqp2i-capital-investment-in-water-infrastructure-will-expand-regulated-base-t1di\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for California Water Service Group on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>Mixed signals so far, right? If you want to make up your own mind quickly, it is worth looking at the underlying numbers and weighing <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/utilities/nyse-cwt/california-water-service-group\" rel=\"noopener noreferrer\" target=\"_blank\">2 key rewards and 3 important warning signs</a> for yourself.</p> <h2>See What Else Is Out There</h2> <p>CWT is working through thinner 12.8% margins, tighter interest and dividend coverage, and a P/E of 20.7x that some investors may find demanding.</p> <p>If those margin and coverage pressures make you uncomfortable, you might want to compare CWT with <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/us\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (41 results)</a> that can handle earnings bumps with stronger cash coverage and less financial strain.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-27 10:11:27",
            "link": "https://simplywall.st/stocks/us/utilities/nyse-cwt/california-water-service-group/news/california-water-service-group-cwt-margin-compression-tests",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Did Stronger 2025 Earnings and Unused Buybacks Just Shift Trisura Group's (TSX:TSU) Investment Narrative?",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>Trisura Group Ltd. recently reported its full-year 2025 results, with net income of CA$142.25 million versus CA$118.92 million a year earlier, and basic earnings per share from continuing operations rising to CA$2.98 from CA$2.49.</li> <li>Despite having active buyback programs announced in December 2024 and December 2025, Trisura did not repurchase any shares in the reported periods, signaling that earnings growth rather than capital returns has been the primary driver of its recent story.</li> <li>We‚Äôll now examine how this stronger full-year earnings performance, alongside unused buyback authorizations, may influence Trisura‚Äôs existing investment narrative.</li> </ul><p>This technology could replace computers: discover <a class=\"company-report-links\" data-vars-link-type=\"intro\" href=\"https://simplywall.st/discover/investing-ideas/282/quantum-computing-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">22 stocks that are working to make quantum computing a reality</a>.</p><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Trisura Group Investment Narrative Recap</h2><p>To own Trisura, you need to believe in its specialty insurance model, disciplined underwriting, and the potential of its expanding U.S. platforms to compound earnings over time. The stronger 2025 net income and EPS support that core thesis, while the lack of buybacks so far does not materially change the near term focus on execution in U.S. specialty lines or the key risk that rapid expansion could test Trisura‚Äôs risk controls.</p> <p>The full year 2025 earnings release is the clearest link to this story, with net income rising to CA$142.25 million and basic EPS from continuing operations up to CA$2.98. For investors watching catalysts like U.S. growth and margin progression, this result anchors the narrative in actual performance rather than in the unused buyback programs, which so far sit more as optional tools than active drivers of shareholder returns.</p> <p>Yet behind the headline earnings progress, investors should be aware of the risk that scaling U.S. Surety and Specialty faster than risk controls can keep up...</p> <p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/ca/insurance/tsx-tsu/trisura-group-shares/gl6wdhyp-us-surety-and-specialty-expansion-will-open-new-opportunities-2wuy\" rel=\"noopener noreferrer\" target=\"_blank\">Read the full narrative on Trisura Group (it's free!)</a></p><p>Trisura Group's narrative projects CA$4.0 billion revenue and CA$208.8 million earnings by 2028. This requires 8.2% yearly revenue growth and about a CA$87 million earnings increase from CA$121.5 million today.</p><p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/ca/insurance/tsx-tsu/trisura-group-shares/gl6wdhyp-us-surety-and-specialty-expansion-will-open-new-opportunities-2wuy\" rel=\"noopener noreferrer\" target=\"_blank\">Uncover how Trisura Group's forecasts yield a CA$56.75 fair value</a>, a 24% upside to its current price.</p><h2>Exploring Other Perspectives</h2><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://simplywall.st/stocks/ca/insurance/tsx-tsu/trisura-group-shares\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"TSX:TSU 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/0ff90050-ee2d-4688-91ec-f300abf88494/chart/quote-price\" width=\"746\"/></a><figcaption>TSX:TSU 1-Year Stock Price Chart</figcaption></figure> <p>Two Simply Wall St Community valuations for Trisura span a wide CA$56.75 to CA$91.53 range, underscoring how differently private investors view its earnings power. Set this against the recent uplift in reported net income and EPS, and you can see why some market participants focus on execution risks in U.S. specialty lines while others concentrate on long term growth potential.</p><p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/ca/insurance/tsx-tsu/trisura-group-shares\" rel=\"noopener noreferrer\" target=\"_blank\">Explore 2 other fair value estimates on Trisura Group</a> - why the stock might be worth as much as 100% more than the current price!</p><h2>Reach Your Own Conclusion</h2><p>Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.</p><ul><li>A great starting point for your Trisura Group research is our analysis highlighting <a class=\"company-report-links\" data-vars-link-type=\"conclusion\" href=\"https://simplywall.st/stocks/ca/insurance/tsx-tsu/trisura-group-shares\" rel=\"noopener noreferrer\" target=\"_blank\">4 key rewards</a> that could impact your investment decision.</li><li><a class=\"company-report-links\" data-vars-link-type=\"conclusion\" href=\"https://simplywall.st/stocks/ca/insurance/tsx-tsu/trisura-group-shares\" rel=\"noopener noreferrer\" target=\"_blank\">Our free Trisura Group research report</a> provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Trisura Group's overall financial health at a glance.</li></ul><h2>Searching For A Fresh Perspective?</h2><p>These stocks are moving-our analysis flagged them today. Act fast before the price catches up:</p><ul><li>AI is about to change healthcare. These <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/434426/healthcare-ai/ca\" rel=\"noopener noreferrer\" target=\"_blank\">4 stocks are working on everything from early diagnostics to drug discovery</a>. The best part - they are all under $10b in market cap - there's still time to get in early.</li><li>The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/434414/ai-penny-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">22 smaller AI-focused companies with strong growth potential</a> through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.</li><li>Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/434418/rare-earth-metal-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">31 best rare earth metal stocks</a> of the very few that mine this essential strategic resource.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Trisura Group might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/ca/insurance/tsx-tsu/trisura-group-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:11:27",
            "link": "https://simplywall.st/stocks/ca/insurance/tsx-tsu/trisura-group-shares/news/did-stronger-2025-earnings-and-unused-buybacks-just-shift-tr",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "NEXTDC H1 2026 Loss Of A$57.2 Million Tests Bullish Growth Narratives",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Data center operator NEXTDC (ASX:NXT) has posted its H1 2026 scorecard with trailing 12 month revenue of A$430.26 million and a loss per share of A$0.089, keeping the company in loss-making territory. The company has seen revenue move from A$195.22 million in H2 2024 to A$205.52 million in H1 2025 and A$221.69 million in H2 2025, while half year EPS tracked at losses of A$0.041, A$0.069 and A$0.028 over the same periods. This sets the scene for investors to weigh strong top line momentum against pressure on margins.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/au/software/asx-nxt/nextdc-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for NEXTDC.</a> <p>With the numbers on the table, the next step is to test them against the prevailing stories around NEXTDC, highlighting where the earnings release supports the narratives and where it pushes back.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_generic_community_narrative\" href=\"https://simplywall.st/features/community-narratives\" rel=\"noopener noreferrer\" target=\"_blank\">Curious how numbers become stories that shape markets? Explore Community Narratives</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/au/software/asx-nxt/nextdc-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"ASX:NXT Revenue &amp; Expenses Breakdown as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/b310dddd-b160-496d-aa26-e7835ce893fc/chart/revenue-and-expenses-breakdown?date=2026-02-26\" width=\"746\"/></a><figcaption>ASX:NXT Revenue &amp; Expenses Breakdown as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Trailing Losses Still Meaningful At A$57.2 Million</h2> <ul> <li>On a trailing 12 month view to H1 2026, NEXTDC booked a net loss of A$57.2 million on A$430.3 million in revenue, with basic EPS at a loss of A$0.089 per share.</li> <li>Bears highlight that losses have grown at about 30.5% per year over the past five years, and this trailing 12 month loss sits in that context, while:\n    <ul> <li>Net income on a trailing basis was A$60.5 million in loss at H2 2025 and A$65.3 million in loss at H1 2025, so the current A$57.2 million loss still reflects a business that is not covering its costs.</li> <li>Half year figures also show losses each period, with A$17.9 million loss in H2 2025, A$42.7 million loss in H1 2025 and A$22.6 million loss in H2 2024, which supports the bearish focus on persistent negative earnings.</li> </ul> </li> </ul> <h2>High Revenue Growth Forecast Versus Ongoing Unprofitability</h2> <ul> <li>Revenue is forecast to grow at 26.93% per year, faster than the Australian market forecast of 6.1% per year, while forecasts also indicate NEXTDC is not expected to be profitable over the next three years.</li> <li>What stands out for a bullish view is that strong forecast revenue growth sits alongside continuing losses, which creates a clear tension, because:\n    <ul> <li>Recent half year revenue has moved from A$195.2 million in H2 2024 to A$205.5 million in H1 2025 and A$221.7 million in H2 2025, so the top line has been stepping up while net income for those halves remained in loss between A$17.9 million and A$42.7 million.</li> <li>On a trailing 12 month basis, revenue rose from A$400.7 million at H1 2025 to A$430.3 million at H1 2026, but basic EPS stayed in loss between A$0.089 and A$0.112 per share, which challenges any bullish assumption that revenue growth alone is quickly translating into profitability.</li> </ul> </li> </ul> Analysts and long term holders are watching whether this mix of 26.93% revenue growth and ongoing losses can eventually line up with a clearer path to profits, or whether expectations start to cool once the cash cost of that growth is front and centre. <a class=\"company-report-links\" data-vars-link-type=\"cta_consensus_narrative_link\" href=\"https://simplywall.st/stock/ASX/NXT\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üìä Read the what the Community is saying about NEXTDC.</strong></a> <h2>Rich P/S Multiple With Less Than One Year Cash Runway</h2> <ul> <li>The shares around A$14.34 trade on a P/S of 21.4x, compared with peers at 13x and a global IT industry average of 1.4x, while the company‚Äôs cash runway is flagged at less than one year.</li> <li>Critics argue this combination of a high sales multiple and short cash runway heightens financing risk, and the earnings profile backs up that concern, because:\n    <ul> <li>With trailing 12 month revenue of A$430.3 million and a net loss of A$57.2 million, NEXTDC is still consuming cash rather than generating it, which matters when runway is under a year.</li> <li>Forecasts that the company is not expected to be profitable over the next three years mean any additional capital, whether debt or equity, would likely be raised against that 21.4x P/S, which bears see as stretched versus both peers at 13x and the wider IT group at 1.4x.</li> </ul> </li> </ul> <h2>Next Steps</h2> <p>Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on NEXTDC's <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://www.simplywall.st/stocks/au/software/asx-nxt/nextdc-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\">growth</a> and its <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://www.simplywall.st/stocks/au/software/asx-nxt/nextdc-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">valuation</a> to see if today's price is a bargain. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> now so you don't miss the next big move.</p> <p>All this leaves a mixed picture. If you are unsure where you land, move quickly to check the full balance of risks and rewards in our <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/au/software/asx-nxt/nextdc-shares\" rel=\"noopener noreferrer\" target=\"_blank\">1 key reward and 2 important warning signs</a>.</p> <h2>See What Else Is Out There</h2> <p>NEXTDC is still loss making with a A$57.2 million trailing loss, a rich 21.4x P/S multiple and a cash runway flagged at under one year.</p> <p>If that mix of high valuation and tight funding window feels uncomfortable, it is worth checking our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/au\" rel=\"noopener noreferrer\" target=\"_blank\">7 resilient stocks with low risk scores</a> to quickly focus on companies with more resilient profiles.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if NEXTDC might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/au/software/asx-nxt/nextdc-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:06:00",
            "link": "https://simplywall.st/stocks/au/software/asx-nxt/nextdc-shares/news/nextdc-h1-2026-loss-of-a572-million-tests-bullish-growth-nar",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "A Look At Kyndryl Holdings (KD) Valuation After Control Weaknesses And Executive Departures",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Kyndryl Holdings (KD) has been under pressure after disclosing material weaknesses in internal controls, delaying a quarterly filing, and announcing the abrupt exit of its CFO and General Counsel, developments now tied to multiple securities class actions.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/us/software/nyse-kd/kyndryl-holdings\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for Kyndryl Holdings.</a></p> <p>The accounting review and executive departures have clearly weighed on sentiment, with a 30 day share price return of 48.34% decline and a year to date share price return of 51.71% decline. The 1 year total shareholder return of 67.37% decline signals fading momentum despite recent AI and cybersecurity announcements.</p> <p>If you are reassessing your tech exposure after Kyndryl's recent volatility, it could be a good time to look at <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_ai_infrastructure\" href=\"https://simplywall.st/discover/investing-ideas/473744/ai-infrastructure-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">33 AI infrastructure stocks</a> as potential AI infrastructure opportunities beyond a single stock.</p> <p>With KD now trading at $12.31 and data implying a sizeable intrinsic and target price discount, the key question is whether current legal and control risks are already reflected in the price or whether the market still expects weaker growth ahead.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Most Popular Narrative: 35.2% Undervalued</h2> <p>At $12.31, the most followed narrative implies Kyndryl Holdings could trade closer to a fair value of $19, using a detailed cash flow and earnings framework.</p> <blockquote> <p><em>The company's focus on expanding AI, data, and cybersecurity services, supported by investments in proprietary initiatives like Kyndryl Bridge and new alliances such as Databricks, is allowing Kyndryl to address rising complexity and security requirements, supporting both higher margins and new revenue streams.</em></p> </blockquote> <p><em><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/p9m3ecoh-digital-transformation-and-hybrid-cloud-will-create-a-resilient-future-0mb6\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></em></p> <p>Curious what kind of revenue mix and profit profile could back that $19 fair value tag? The narrative leans on compound earnings growth, firmer margins, and a valuation multiple that steps down from today yet still assumes confidence in long term cash generation. The real story is in how modest top line assumptions and stronger profitability combine to get there. Want to see exactly how those moving parts add up?</p> <p><strong>Result: Fair Value of $19 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/p9m3ecoh-digital-transformation-and-hybrid-cloud-will-create-a-resilient-future-0mb6\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, you also have to weigh ongoing revenue pressure from legacy contracts, as well as the new legal, control, and filing issues that could reshape how confident the market feels about KD.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/us/software/nyse-kd/kyndryl-holdings\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this Kyndryl Holdings narrative.</a></p> <h2>Next Steps</h2> <p>Given all this, do you feel the story leans more toward concern or opportunity? Act while sentiment is still split and weigh both sides for yourself by checking out the <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/software/nyse-kd/kyndryl-holdings\" rel=\"noopener noreferrer\" target=\"_blank\">4 key rewards and 2 important warning signs</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If this Kyndryl story has you rethinking your tech exposure, do not stop here. Use the screener to spot other ideas before the crowd moves on.</p> <ul> <li>Target long term compounders by reviewing our list of <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undiscovered_gems\" href=\"https://simplywall.st/discover/investing-ideas/473622/high-quality-undiscovered-gems/us\" rel=\"noopener noreferrer\" target=\"_blank\">screener containing 24 high quality undiscovered gems</a> that combine quality fundamentals with relatively low market attention.</li> <li>Prioritise resilience by focusing on companies in the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/us\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (41 results)</a> where financial strength supports flexibility through different business conditions.</li> <li>Lock in cash flow potential by scanning the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_dividend\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/us\" rel=\"noopener noreferrer\" target=\"_blank\">15 dividend fortresses</a> that highlight income opportunities with higher yields than many headline names.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Kyndryl Holdings might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/us/software/nyse-kd/kyndryl-holdings/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:06:00",
            "link": "https://simplywall.st/stocks/us/software/nyse-kd/kyndryl-holdings/news/a-look-at-kyndryl-holdings-kd-valuation-after-control-weakne",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "BTB REIT Q4 FFO Loss Challenges Income Focused Bullish Narratives",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>BTB Real Estate Investment Trust (TSX:BTB.UN) FY 2025 Results at a Glance</h2> <p>BTB Real Estate Investment Trust (TSX:BTB.UN) has reported its FY 2025 numbers with fourth quarter revenue of $32.3 million and a net loss of $0.9 million, alongside a quarterly Funds From Operations loss of $27.2 million. Over recent quarters, revenue has held in a narrow band between $30.5 million and $34.4 million, while quarterly net income has ranged from a profit of $18.8 million in FY 2024 Q4 to a loss of $0.9 million in FY 2025 Q4. With trailing net profit margin at 17.2% versus 29.8% the prior year and interest coverage highlighted as a weak spot, the focus now is on whether BTB can steady cash flows and margins enough to support its current profile.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/ca/real-estate/tsx-btb.un/btb-real-estate-investment-trust-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for BTB Real Estate Investment Trust.</a> <p>With the headline figures set, the next step is to see how these results line up against the widely held narratives around BTB‚Äôs growth, risk profile and income potential, and where the latest numbers start to challenge those views.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_generic_community_narrative\" href=\"https://simplywall.st/features/community-narratives\" rel=\"noopener noreferrer\" target=\"_blank\">Curious how numbers become stories that shape markets? Explore Community Narratives</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/ca/real-estate/tsx-btb.un/btb-real-estate-investment-trust-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"TSX:BTB.UN Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/33eb3fb0-f5a1-45eb-b668-7a37cec69372/chart/earnings-and-revenue-history?date=2026-02-26\" width=\"746\"/></a><figcaption>TSX:BTB.UN Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <h2>FFO swings from $10.2 million to a $27.2 million loss</h2> <ul> <li>BTB moved from Funds From Operations of $10.2 million in FY 2025 Q3 to a $27.2 million FFO loss in Q4, even though revenue sat in a tight band between $30.5 million and $34.4 million across the year.</li> <li>What stands out for a cautious, more bearish view is that this FFO volatility comes on top of slower trailing revenue growth of 2.6% per year and a lower net margin of 17.2%. Together, these figures point to earnings that are more sensitive to costs and interest expense than the long term 6.5% annual earnings trend might suggest.\n    <ul> <li>Trailing 12 month net income of $22.4 million is well below the $42.2 million level reported a quarter earlier on a trailing basis, which lines up with the weaker margin picture.</li> <li>Bears highlighting interest coverage as a major risk get some support here because weaker cash generation makes it harder to comfortably meet those interest payments.</li> </ul> </li> </ul> üìâ Skeptics who focus on that $27.2 million FFO loss may want the full cautionary case before deciding what comes next: <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bear_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêª BTB Real Estate Investment Trust Bear Case</strong></a> <h2>Margins fall from 29.8% to 17.2%</h2> <ul> <li>Over the last 12 months, BTB‚Äôs net profit margin sits at 17.2%, down from 29.8% the prior year, even though trailing revenue held around $130.1 million to $131.8 million.</li> <li>Supportive investors who take a more bullish angle might argue that the 6.5% per year earnings growth over five years shows the business has produced profits over time. However, the latest year of weaker margins and negative earnings relative to that trend pushes them to focus on whether this is a temporary squeeze or a more persistent shift.\n    <ul> <li>The trailing 12 month net income of $22.4 million compares with $38.7 million a year earlier on a trailing basis, which is a clear step down even though revenue is broadly similar.</li> <li>With interest payments flagged as not well covered by earnings, the margin compression directly feeds into that risk, since there is less profit left after operating costs to service debt.</li> </ul> </li> </ul> <h2>P/E of 16.3x with a DCF fair value of $5.68</h2> <ul> <li>The units trade at a P/E of 16.3x versus a peer average of 11.4x and a Global REITs average of about 16x, while the DCF fair value used here is $5.68 per unit compared to a current price of $4.12. This implies roughly a 27.5% discount to that DCF fair value estimate.</li> <li>What is interesting for a valuation focused bullish angle is that, despite softer margins and weaker interest coverage, the P/E sits above peers yet the unit still screens at a discount to DCF fair value. This sets up a clear tension between earnings based multiples and cash flow based valuation.\n    <ul> <li>The trailing 12 month revenue growth rate of 2.6% per year, below the 6.1% Canadian market benchmark, helps explain why some investors might hesitate to pay more even with that DCF gap.</li> <li>At the same time, a 17.2% net margin and positive trailing net income of $22.4 million give bulls some hard numbers to point to when they argue the current $4.12 price already reflects a good part of the recent pressure.</li> </ul> </li> </ul> If you want to see how other investors are weighing that 27.5% DCF gap against the earnings pressure, it is worth checking what the community is debating around BTB right now: <a class=\"company-report-links\" data-vars-link-type=\"cta_consensus_narrative_link\" href=\"https://simplywall.st/stock/TSX/BTB.UN\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üìä Read the what the Community is saying about BTB Real Estate Investment Trust.</strong></a> <h2>Next Steps</h2> <p>Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on BTB Real Estate Investment Trust's <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://www.simplywall.st/stocks/ca/real-estate/tsx-btb.un/btb-real-estate-investment-trust-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\">growth</a> and its <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://www.simplywall.st/stocks/ca/real-estate/tsx-btb.un/btb-real-estate-investment-trust-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">valuation</a> to see if today's price is a bargain. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> now so you don't miss the next big move.</p> <p>If this mix of pressure on FFO and interest coverage has you on the fence, take a moment to check the underlying drivers for yourself. Then weigh up the balance of <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/ca/real-estate/tsx-btb.un/btb-real-estate-investment-trust-shares\" rel=\"noopener noreferrer\" target=\"_blank\">1 key reward and 3 important warning signs</a>.</p> <h2>See What Else Is Out There</h2> <p>BTB‚Äôs sharp move from a $10.2 million FFO profit to a $27.2 million loss, weaker 17.2% margins and pressure on interest coverage all highlight a balance sheet that looks stretched.</p> <p>If that mix of FFO swings and interest coverage risk feels uncomfortable, you can quickly compare it with companies that score better on debt and cash strength using our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/ca\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (10 results)</a>.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if BTB Real Estate Investment Trust might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/ca/real-estate/tsx-btb.un/btb-real-estate-investment-trust-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:06:00",
            "link": "https://simplywall.st/stocks/ca/real-estate/tsx-btb.un/btb-real-estate-investment-trust-shares/news/btb-reit-q4-ffo-loss-challenges-income-focused-bullish-narra",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Geron (GERN) Q4 Loss Of US$31.1 Million Tests Bullish Profitability Narrative",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Geron (GERN) has just posted its FY 2025 results, with Q4 total revenue of US$48.0 million and a basic EPS loss of US$0.05, alongside trailing twelve month revenue of US$183.9 million and a TTM basic EPS loss of US$0.13. Over recent periods the company has seen quarterly revenue move between US$39.6 million and US$49.0 million, while basic EPS losses have ranged from US$0.02 to US$0.05 per quarter. This sets the backdrop for how investors assess the current TTM net loss of US$85.8 million and the pressure this puts on margins.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gern/geron\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Geron.</a> <p>With the headline numbers on the table, the next step is to line these results up against the main stories around Geron and see where the financials support those narratives and where they start to push back.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/iajwo4yv-aging-population-trends-will-expand-hematology-market-opportunity-sb98\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Geron</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gern/geron/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqGS:GERN Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/46c7021c-c6f2-4a96-8e04-ee2bca322ba5/chart/earnings-and-revenue-history?date=2026-02-26\" width=\"746\"/></a><figcaption>NasdaqGS:GERN Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Losses stay wide at US$85.8 million TTM</h2> <ul> <li>Over the last twelve months, Geron booked a net loss of US$85.8 million on US$183.9 million of revenue, with quarterly net losses in FY 2025 ranging from US$16.4 million in Q2 to US$31.1 million in Q4.</li> <li>Consensus narrative points to a path toward higher margins, but the current loss base is still sizeable:\n    <ul> <li>Analysts see revenue growing about 56.2% per year with margins moving from a loss of 53.5% today to a 27.9% margin in around three years, while the latest TTM figures still show meaningful losses on US$183.9 million of revenue.</li> <li>This creates a gap between the balanced view that Geron can support positive earnings in future and the current picture, where every one of the last six reported quarters, including Q4 FY 2025, shows a net loss of at least US$16.4 million.</li> </ul> </li> </ul> <h2>P/S of 5.8x vs industry 12.5x</h2> <ul> <li>Geron is currently trading on a P/S of 5.8x, compared with 12.5x for the wider US biotech group and 6.9x for its peer set, while the shares trade at US$1.67 versus a DCF fair value input of about US$19.01.</li> <li>Bulls highlight this valuation gap as a key part of their case, but the earnings profile gives important context:\n    <ul> <li>Bullish expectations look for revenue growth of 65.9% per year and earnings of US$379.0 million by around 2028, yet the latest TTM net loss is US$85.8 million, so the step change from today‚Äôs loss-making base is large.</li> <li>At the same time, the current 5.8x P/S and the difference between the US$1.67 share price and the US$19.01 DCF fair value input heavily support the bullish argument that the market is pricing Geron well below those optimistic growth and margin assumptions.</li> </ul> </li> </ul> If you want to see how optimistic investors are connecting these numbers to a long term story, check out the detailed bull case for Geron: <a class=\"company-report-links\" data-vars-link-type=\"cta_bull_narrative_link\" href=\"https://simplywall.st/narratives/0xbj3pwr-precision-medicine-and-telomerase-inhibition-will-expand-therapeutic-markets\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêÇ Geron Bull Case</strong></a> <h2>Five year loss trend vs 62.6% earnings growth forecast</h2> <ul> <li>Over the past five years, losses have widened at about 6.3% per year, and on the latest data Geron remains unprofitable, while forward-looking models point to earnings growth of about 62.6% per year and an expectation of profitability within roughly three years.</li> <li>Bears focus on this track record as a counter to the growth story:\n    <ul> <li>Skeptical views stress that recent history still shows a sequence of quarterly net losses, including US$31.1 million in Q4 FY 2025 and US$85.8 million over the latest twelve months, which they see as evidence that scaling revenue has not yet translated into positive earnings.</li> <li>Against that, the forecast path to profitability within three years and the projected 62.6% annual earnings growth directly challenge the bearish concern that losses will simply continue on the same 6.3% five year trend without improving.</li> </ul> </li> </ul> Skeptical about that improvement story? You can walk through the numbers behind the cautious view in more detail here: <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/cvtzbdzk-drug-pricing-controls-and-approval-delays-will-curb-viability\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª Geron Bear Case</strong></a> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/iajwo4yv-aging-population-trends-will-expand-hematology-market-opportunity-sb98\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Geron on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>If the mix of optimism and caution in Geron‚Äôs story leaves you unsure, take a closer look now and weigh the evidence for yourself. You can also review the company‚Äôs <a class=\"company-report-links\" data-vars-link-type=\"cta_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gern/geron\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards</a> to see what other investors are focusing on.</p> <h2>See What Else Is Out There</h2> <p>Geron is still posting sizeable losses, with US$85.8 million TTM in the red and several years of unprofitable quarters, which may concern risk conscious investors.</p> <p>If that level of ongoing loss makes you want sturdier foundations, check out our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">79 resilient stocks with low risk scores</a> to quickly spot companies with more resilient profiles today.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-27 10:06:00",
            "link": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gern/geron/news/geron-gern-q4-loss-of-us311-million-tests-bullish-profitabil",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Universal Health Services Q4 EPS Strength Reinforces Bullish Margin Narrative",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Universal Health Services (UHS) has wrapped up FY 2025 with fourth quarter revenue of US$4.5b and basic EPS of US$7.19, backed by net income of US$445.9m. The company has seen quarterly revenue move from US$4.1b in Q4 2024 to US$4.5b in Q4 2025, while basic EPS stepped up from US$5.07 to US$7.19 over the same period. On a trailing twelve month view, net profit margin sits at 8.6% versus 7.2% a year earlier, giving investors a clearer view of how earnings are converting into profit.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/healthcare/nyse-uhs/universal-health-services\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Universal Health Services.</a> <p>With the latest numbers on the table, the next step is to see how this earnings profile lines up with the key narratives around UHS, highlighting where the story is confirmed and where expectations might need to be revisited.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/rdizidzn-lower-medicaid-payments-and-rising-costs-will-erode-margins\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Universal Health Services</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/healthcare/nyse-uhs/universal-health-services/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:UHS Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/dc1969cb-1517-4f94-bfaa-fe82aca6adfc/chart/earnings-and-revenue-history?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:UHS Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>TTM earnings up 30.4% with profit margin at 8.6%</h2> <ul> <li>Over the trailing twelve months, UHS generated US$23.42 in basic EPS and US$1.5b in net income on US$17.4b of revenue, with net profit margin at 8.6% compared with 7.2% a year earlier.</li> <li>What stands out for the bullish view is that this 30.4% trailing earnings growth and higher margin line up with arguments about expanding behavioral health and outpatient capacity. At the same time, the consensus narrative also flags future Medicaid payment reductions, so current profitability and the longer term policy overhang are pulling in different directions.</li> </ul> <h2>Low 8.6x P/E against healthcare peers</h2> <ul> <li>UHS trades on a trailing P/E of 8.6x compared with 23.6x for the wider US healthcare industry and 27x for peers, even though trailing earnings have grown 30.4% year over year and have risen about 7.3% per year over the last five years according to the supplied data.</li> <li>Bulls point to this apparent valuation gap and recent earnings strength as support for their case that the company could justify higher pricing. Yet the current share price of US$204.33 still sits well below the cited DCF fair value of about US$588.00 and below the allowed analyst target of US$253.00, which means the bullish argument about underappreciated growth is being made against forecasts that show earnings and revenue growth of 3.1% and 4.2% per year respectively, both slower than the US market in the inputs.\n    <ul> <li>That tension between a low P/E and slower forecast growth is central to the bullish narrative that outpatient and behavioral expansion, plus technology efficiencies, could support higher margins than the consensus currently embeds.</li> <li>At the same time, the supplied data notes the stock trading materially below the DCF fair value and below US$253.00, which bullish investors treat as evidence that the market is not fully crediting the 30.4% trailing earnings growth and 8.6% margin achieved so far.</li> </ul> </li> </ul> <p>Bulls argue that the market is underestimating how sustained earnings growth and margin resilience could shift sentiment if current trends hold, especially with the stock on an 8.6x P/E and trading below both DCF fair value and the US$253.00 analyst target. <a class=\"company-report-links\" data-vars-link-type=\"cta_bull_narrative_link\" href=\"https://simplywall.st/narratives/6pqkl3yw-new-outpatient-facilities-and-telehealth-will-unlock-secular-market-demand\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêÇ Universal Health Services Bull Case</strong></a></p> <h2>High debt and policy risks against slower 3.1% EPS growth</h2> <ul> <li>The inputs highlight a high level of debt on the balance sheet alongside forecast earnings growth of about 3.1% per year and revenue growth of 4.2% per year, both cited as slower than the broader US market even though trailing net income over the last year is US$1.5b.</li> <li>Bears focus on that leverage and on regulatory items such as expected US$360m to US$400m annual cuts to Medicaid supplemental payments by 2032, arguing that slower forecast growth plus higher interest and capital needs make it harder to sustain the 8.6% margin, even though recent results show improved profitability and 30.4% trailing earnings growth that so far have run ahead of those cautious assumptions.\n    <ul> <li>Critics highlight that if net benefit from Medicaid programs falls while revenue growth tracks closer to the 4.2% forecast, the combination of debt servicing and lower reimbursement could pressure earnings even if current EPS of US$23.42 on a trailing basis remains solid today.</li> <li>What challenges the bearish stance somewhat is that, despite these risks being flagged, analysts in the supplied data still reference earnings that have grown 7.3% per year over five years and a current margin above last year, which suggests the operational picture has been resilient so far even as future policy changes are being debated.</li> </ul> </li> </ul> <p>Skeptics warn that high leverage and policy changes could matter more than recent EPS strength, especially if future growth sits near 3.1% while debt stays elevated. <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/rdizidzn-lower-medicaid-payments-and-rising-costs-will-erode-margins\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª Universal Health Services Bear Case</strong></a></p> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/rdizidzn-lower-medicaid-payments-and-rising-costs-will-erode-margins\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Universal Health Services on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>With the bullish and bearish angles laid out, how do they stack up for you right now, and what feels most important for your own portfolio decisions? Our analysis flags both risks and rewards that investors are watching closely, so it is worth checking the full breakdown before you settle on a view, starting with <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/healthcare/nyse-uhs/universal-health-services\" rel=\"noopener noreferrer\" target=\"_blank\">4 key rewards and 1 important warning sign</a>.</p> <h2>Explore Alternatives</h2> <p>UHS carries high debt and faces potential Medicaid payment cuts, while forecast earnings and revenue growth in the supplied data sit at modest single digit rates.</p> <p>If that mix of leverage and policy risk feels heavy for your portfolio, take a look at our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">79 resilient stocks with low risk scores</a> to find companies with steadier profiles.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-27 10:00:58",
            "link": "https://simplywall.st/stocks/us/healthcare/nyse-uhs/universal-health-services/news/universal-health-services-q4-eps-strength-reinforces-bullish",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Assessing BrightView Holdings (BV) Valuation After Expanded Golf Management Role At The Villages",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>BrightView Holdings (BV) shares are in focus after its BrightView Landscapes unit expanded its golf management role at The Villages in Florida, where it now oversees more than half of the community‚Äôs 400 golf holes.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-bv/brightview-holdings\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for BrightView Holdings.</a></p> <p>The latest contract win comes as BrightView‚Äôs 30 day share price return of 5.39% and 90 day share price return of 10.06% point to building momentum. At the same time, the 3 year total shareholder return of about 12x contrasts with a 5 year total shareholder return decline of 12.86%.</p> <p>If this golf expansion has you thinking about longer term themes in infrastructure and services, it could be worth scanning our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_power_grid\" href=\"https://simplywall.st/discover/investing-ideas/473750/power-grid-technology-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">23 power grid technology and infrastructure stocks</a> as another way to look for potential opportunities.</p> <p>With BrightView shares up over the past 3 months and trading at a reported discount to some analyst and intrinsic value estimates, the key question is whether there is still an opportunity here or if the market is already pricing in future growth.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Most Popular Narrative: 15% Undervalued</h2> <p>BrightView Holdings' most followed narrative sets a fair value of about $16.34 per share, compared with the last close at $13.89. This frames the current debate around upside versus execution risk.</p> <blockquote> <p><em>The \"One BrightView\" strategy is driving substantial cost savings and operating leverage through procurement centralization, technology investments, and large-scale fleet upgrades, which is directly impacting operating margins and net earnings, with further margin expansion expected as these initiatives scale.</em></p> </blockquote> <p><em>Read the complete narrative.</em> <a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/oxqxa3ns-expansion-into-10-branches-will-secure-urban-green-demand-d4qd\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></p> <p>Curious what kind of revenue growth, margin lift, and future earnings multiple need to come together to support that fair value? The projections behind this story lean heavily on improving profitability, rising recurring revenue and a lower valuation multiple than many investors might assume. The full narrative lays out how those moving parts fit together and what would need to go right for the numbers to line up.</p> <p><strong>Result: Fair Value of $16.34 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/oxqxa3ns-expansion-into-10-branches-will-secure-urban-green-demand-d4qd\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, this story could look very different if macro headwinds keep delaying client projects, or if cost savings and project to maintenance conversions fall short of expectations.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-bv/brightview-holdings\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this BrightView Holdings narrative.</a></p> <h2>Next Steps</h2> <p>If this mix of potential upside and clear risks leaves you on the fence, take time while the data is fresh to shape your own view with <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/commercial-services/nyse-bv/brightview-holdings\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards and 4 important warning signs</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If BrightView has you thinking more broadly about where to put your money to work next, do not stop here; widen your search before the market moves on.</p> <ul> <li>Target quality first by checking companies that combine strong fundamentals with sturdy finances through our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/us\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (41 results)</a>.</li> <li>Hunt for potential value by scanning our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 high quality undervalued stocks</a> that filters for companies with solid business profiles trading below their assessed worth.</li> <li>Prioritise resilience by reviewing our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">79 resilient stocks with low risk scores</a> that highlights businesses with lower risk scores for steadier portfolio anchors.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if BrightView Holdings might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/us/commercial-services/nyse-bv/brightview-holdings/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:00:58",
            "link": "https://simplywall.st/stocks/us/commercial-services/nyse-bv/brightview-holdings/news/assessing-brightview-holdings-bv-valuation-after-expanded-go",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Reassessing Novo Nordisk (CPSE:NOVO B) After Sharp Share Price Declines",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>If you are looking at Novo Nordisk and wondering whether the current share price still lines up with the company‚Äôs long term story, you are not alone.</li> <li>The stock last closed at DKK 238.6, with returns of 22.4% decline over 7 days, 39.4% decline over 30 days, 27.8% decline year to date, 61.8% decline over 1 year and 50.0% decline over 3 years, while the 5 year return stands at 19.6%.</li> <li>These swings have arrived alongside ongoing attention on Novo Nordisk‚Äôs role in diabetes and weight management treatments, as well as regulatory and competitive headlines that keep the company in the spotlight. Together, these factors help explain why the share price has been so reactive, as investors reassess expectations and risk.</li> <li>Against that backdrop, Novo Nordisk currently scores 5 out of 6 on our valuation checks, as shown by our <a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">valuation score</a>. Next, we will look at how different valuation methods line up on the stock and finish with an approach that can give you an even clearer view of what the market is pricing in.</li> </ul> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_industry_underperformer\" href=\"https://www.simplywall.st/stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares/future\" rel=\"noopener noreferrer\" target=\"_blank\">Find out why Novo Nordisk's -61.8% return over the last year is lagging behind its peers.</a></p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Approach 1: Novo Nordisk Discounted Cash Flow (DCF) Analysis</h3> <p>A Discounted Cash Flow, or DCF, model estimates what a business could be worth today by projecting its future cash flows and discounting them back to the present.</p> <p>For Novo Nordisk, the model uses a 2 stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is DKK 52,097.16m. Analyst and extrapolated projections suggest free cash flow reaching DKK 145,840.33m in 2030, with a path that includes DKK 41,926.80m in 2026 and DKK 207,436.58m in 2035. Simply Wall St uses analyst estimates where available, then extends them using its own growth assumptions for the later years.</p> <p>Discounting these projected cash flows back to today gives an estimated intrinsic value of DKK 1,072.30 per share. Compared with the recent share price of DKK 238.60, the DCF output suggests the market price is at a 77.7% discount to this estimate, which indicates that the stock appears materially undervalued on this model alone.</p> <p><strong>Result: UNDERVALUED</strong></p> <p>Our Discounted Cash Flow (DCF) analysis suggests Novo Nordisk is undervalued by 77.7%. Track this in your <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_undervalued\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_undervalued\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>, or discover <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">231 more high quality undervalued stocks</a>.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NOVO B Discounted Cash Flow as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/71be77aa-1311-4447-b4b8-bcb7f8815b88/chart/dcf?date=2026-02-26\" width=\"746\"/></a><figcaption>NOVO B Discounted Cash Flow as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"dcf_explainer_cta\" href=\"https://www.simplywall.st/stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Novo Nordisk.</a></p> <h3>Approach 2: Novo Nordisk Price vs Earnings</h3> <p>For a profitable company like Novo Nordisk, the P/E ratio is a useful snapshot of how much investors are paying for each unit of earnings. It reflects what the market is willing to pay today for the company‚Äôs current profit stream.</p> <p>In simple terms, higher growth expectations and lower perceived risk tend to support a higher P/E, while slower expected growth or higher risk usually line up with a lower, more conservative P/E. Novo Nordisk currently trades on a P/E of 10.35x, compared with the Pharmaceuticals industry average of 22.54x and a peer average of 26.08x. That raw comparison alone might suggest the stock is priced more cautiously than many of its peers.</p> <p>Simply Wall St‚Äôs Fair Ratio for Novo Nordisk is 25.04x. This is a proprietary P/E level that reflects factors such as the company‚Äôs earnings growth profile, profit margins, risk characteristics, industry, and market cap. Because it builds in these company specific drivers, it can be more informative than a simple peer or industry comparison. With the current P/E of 10.35x sitting well below the Fair Ratio of 25.04x, the multiple based view points to the shares looking undervalued on earnings.</p> <p><strong>Result: UNDERVALUED</strong></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"CPSE:NOVO B P/E Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/71be77aa-1311-4447-b4b8-bcb7f8815b88/chart/pe-multiple-vs-industry?date=2026-02-26\" width=\"746\"/></a><figcaption>CPSE:NOVO B P/E Ratio as at Feb 2026</figcaption></figure> <p>P/E ratios tell one story, but what if the real opportunity lies elsewhere? <a class=\"company-report-links\" data-vars-link-type=\"cta_preferred_multiple_contextual\" href=\"https://simplywall.st/discover/investing-ideas/473625/top-founder-led-companies/global\" rel=\"noopener noreferrer\" target=\"_blank\">Start investing in legacies, not executives. Discover our 98 top founder-led companies</a>.</p> <h3>Upgrade Your Decision Making: Choose your Novo Nordisk Narrative</h3> <p>Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, a simple way for you to attach a clear story about a company to the numbers you are seeing, including your view on fair value and your own assumptions for future revenue, earnings and margins.</p> <p>A Narrative connects three pieces you already think about: what you believe is happening in the business, how that might flow through to a financial forecast, and what that implies for a fair value you can compare with today‚Äôs share price.</p> <p>On Simply Wall St, Narratives are available on the Community page and are used by millions of investors, so you can quickly see different views on Novo Nordisk and how other investors translate their thesis into numbers without needing to build a full model yourself.</p> <p>Because each Narrative pairs a user‚Äôs fair value with the current market price, it gives you a practical way to decide whether the gap between value and price is wide enough for you to consider buying, waiting, or taking some money off the table, all within a consistent framework.</p> <p>Narratives stay current because they refresh when new information such as earnings releases, regulatory updates or major news is incorporated, so the story, forecast and fair value do not sit frozen in time.</p> <p>For Novo Nordisk right now, one investor Narrative on Simply Wall St estimates fair value at DKK 287.0 while another sits at DKK 1,036.18, which shows how two people looking at the same company can reach very different conclusions once they plug in their own expectations.</p> <p>Do you think there's more to the story for Novo Nordisk? <a class=\"company-report-links\" data-vars-link-type=\"cta_create_narrative_community\" href=\"https://simplywall.st/stock/CPSE/NOVO%20B\" rel=\"noopener noreferrer\" target=\"_blank\">Head over to our Community to see what others are saying!</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"CPSE:NOVO B 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/71be77aa-1311-4447-b4b8-bcb7f8815b88/chart/quote-price?date=2026-02-26\" width=\"746\"/></a><figcaption>CPSE:NOVO B 1-Year Stock Price Chart</figcaption></figure> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Novo Nordisk might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:00:58",
            "link": "https://simplywall.st/stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares/news/reassessing-novo-nordisk-cpsenovo-b-after-sharp-share-price",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Is Houlihan Lokey (HLI) Fairly Priced After Recent Share Price Softness And Strong Multi‚ÄëYear Gains",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>If you are wondering whether Houlihan Lokey‚Äôs current share price reflects its true worth, you are not alone. This article is designed to help you size up what you are really paying for.</li> <li>The stock last closed at US$169.10, with returns of 1.8% over the past week, a 5.9% decline over the past month, a 4.1% decline year to date, a 0.5% gain over the past year, 86.6% over three years and 182.7% over five years, which may leave you questioning whether the recent path justifies today‚Äôs price tag.</li> <li>Recent company updates and sector news have kept Houlihan Lokey on investor watchlists, as corporate activity and advisory demand often steer sentiment around investment banks and financial advisors. These headlines give important context to the recent mix of short term softness and longer term strength in the share price.</li> <li>Right now Houlihan Lokey scores 2 out of 6 on our valuation checks, which you can see in detail in our <a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nyse-hli/houlihan-lokey/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">valuation score</a>. We will walk through the usual valuation approaches next and also point you to a more complete way of thinking about value at the end of the article.</li> </ul> <p>Houlihan Lokey scores just 2/6 on our valuation checks. See what other red flags we found in the <a class=\"company-report-links\" data-vars-link-type=\"cta_low_value_score\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nyse-hli/houlihan-lokey/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">full valuation breakdown</a>.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Approach 1: Houlihan Lokey Excess Returns Analysis</h3> <p>The Excess Returns model looks at how much value a company creates above the return that shareholders are estimated to require. It starts from the equity on the balance sheet, then compares the company‚Äôs expected return on that equity to its estimated cost of equity.</p> <p>For Houlihan Lokey, the model uses a Book Value of US$32.92 per share and a Stable EPS of US$9.25 per share, based on weighted future Return on Equity estimates from 4 analysts. The Average Return on Equity used is 25.05%, while the Cost of Equity is US$2.91 per share, implying an Excess Return of US$6.34 per share. The model also factors in a Stable Book Value of US$36.95 per share, sourced from weighted future Book Value estimates from 4 analysts.</p> <p>Combining these inputs, the Excess Returns model arrives at an estimated intrinsic value of about US$178.83 per share. Compared with the recent share price of about US$169.10, this suggests the stock is around 5.4% undervalued. This sits within a reasonable margin of error rather than providing a clear bargain signal.</p> <p><strong>Result: ABOUT RIGHT</strong></p> <p>Houlihan Lokey is fairly valued according to our <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_fairly_valued\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nyse-hli/houlihan-lokey/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Excess Returns</a>, but this can change at a moment's notice. Track the value in your <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_fairly_valued\" href=\"https://www.simplywall.st/watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_fairly_valued\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> and be alerted on when to act.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/diversified-financials/nyse-hli/houlihan-lokey/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"HLI Discounted Cash Flow as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/c70f2d67-69b8-455b-920e-4c3e95539baa/chart/dcf?date=2026-02-26\" width=\"746\"/></a><figcaption>HLI Discounted Cash Flow as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"dcf_explainer_cta\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nyse-hli/houlihan-lokey/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Houlihan Lokey.</a></p> <h3>Approach 2: Houlihan Lokey Price vs Earnings</h3> <p>For profitable companies like Houlihan Lokey, the P/E ratio is a useful shorthand for how much you are paying for each dollar of earnings. It helps you compare what the market is currently willing to pay for the company‚Äôs earnings relative to other options.</p> <p>What counts as a reasonable P/E usually reflects two things: how quickly earnings are expected to grow, and how risky those earnings are perceived to be. Higher expected growth and lower perceived risk can justify a higher P/E, while slower growth or higher risk typically support a lower multiple.</p> <p>Houlihan Lokey currently trades on a P/E of 26.35x. That sits above both the Capital Markets industry average of 23.01x and the peer group average of 15.39x. Simply Wall St‚Äôs Fair Ratio for Houlihan Lokey is 16.22x, which is its proprietary view of what a balanced P/E could look like after factoring in earnings growth, industry, profit margins, market cap and company specific risks.</p> <p>This Fair Ratio can be more informative than a simple peer or industry comparison because it adjusts for the company‚Äôs own characteristics rather than assuming one size fits all. With the current 26.35x P/E sitting above the 16.22x Fair Ratio, the shares look expensive on this metric.</p> <p><strong>Result: OVERVALUED</strong></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/diversified-financials/nyse-hli/houlihan-lokey/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:HLI P/E Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/c70f2d67-69b8-455b-920e-4c3e95539baa/chart/pe-multiple-vs-industry?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:HLI P/E Ratio as at Feb 2026</figcaption></figure> <p>P/E ratios tell one story, but what if the real opportunity lies elsewhere? <a class=\"company-report-links\" data-vars-link-type=\"cta_preferred_multiple_contextual\" href=\"https://simplywall.st/discover/investing-ideas/473625/top-founder-led-companies/us\" rel=\"noopener noreferrer\" target=\"_blank\">Start investing in legacies, not executives. Discover our 20 top founder-led companies</a>.</p> <h3>Upgrade Your Decision Making: Choose your Houlihan Lokey Narrative</h3> <p>Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, which are simply your story about a company expressed through your own assumptions for fair value, future revenue, earnings and margins, linked to a forecast and then to a fair value that you can compare with today‚Äôs price. On Simply Wall St, within the Community page used by millions of investors, Narratives give you an easy way to set out that story in numbers, see how your view differs from others, and quickly spot when your Fair Value is above or below the current price. This can help you decide whether the stock fits your watchlist or portfolio. Narratives also refresh as new information such as news, earnings or updated analyst estimates are added, so your view does not stay frozen. For Houlihan Lokey, for example, one investor might align with the higher fair value view around US$242.55 per share while another might lean closer to the lower fair value of US$173 per share, and Narratives make those different perspectives clear and comparable in one place.</p> <p>Do you think there's more to the story for Houlihan Lokey? <a class=\"company-report-links\" data-vars-link-type=\"cta_create_narrative_community\" href=\"https://simplywall.st/stock/NYSE/HLI\" rel=\"noopener noreferrer\" target=\"_blank\">Head over to our Community to see what others are saying!</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/diversified-financials/nyse-hli/houlihan-lokey\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:HLI 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/c70f2d67-69b8-455b-920e-4c3e95539baa/chart/quote-price?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:HLI 1-Year Stock Price Chart</figcaption></figure> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Houlihan Lokey might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/us/diversified-financials/nyse-hli/houlihan-lokey/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-27 10:00:57",
            "link": "https://simplywall.st/stocks/us/diversified-financials/nyse-hli/houlihan-lokey/news/is-houlihan-lokey-hli-fairly-priced-after-recent-share-price",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        }
    ]
}